<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T20:08:10Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:6138442" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:6138442</identifier><datestamp>2018-09-15</datestamp><setSpec>emboj</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">EMBO J</journal-id>
      <journal-id journal-id-type="iso-abbrev">EMBO J</journal-id>
      <journal-id journal-id-type="doi">10.1002/(ISSN)1460-2075</journal-id>
      <journal-id journal-id-type="publisher-id">EMBJ</journal-id>
      <journal-id journal-id-type="hwp">embojnl</journal-id>
      <journal-title-group>
        <journal-title>The EMBO Journal</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0261-4189</issn>
      <issn pub-type="epub">1460-2075</issn>
      <publisher>
        <publisher-name>John Wiley and Sons Inc.</publisher-name>
        <publisher-loc>Hoboken</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC6138442</article-id>
      <article-id pub-id-type="pmcid">PMC6138442</article-id>
      <article-id pub-id-type="pmc-uid">6138442</article-id>
      <article-id pub-id-type="pmid">30143514</article-id>
      <article-id pub-id-type="doi">10.15252/embj.201798358</article-id>
      <article-id pub-id-type="publisher-id">EMBJ201798358</article-id>
      <article-categories>
        <subj-group subj-group-type="overline">
          <subject>Article</subject>
        </subj-group>
        <subj-group subj-group-type="heading">
          <subject>Articles</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>TRIM16 controls assembly and degradation of protein aggregates by modulating the p62âNRF2 axis and autophagy</article-title>
        <alt-title alt-title-type="left-running-head">Kautilya Kumar Jena <italic>etÂ al</italic></alt-title>
      </title-group>
      <contrib-group>
        <contrib id="embj201798358-cr-0001" contrib-type="author">
          <name>
            <surname>Jena</surname>
            <given-names>Kautilya Kumar</given-names>
          </name>
          <xref ref-type="aff" rid="embj201798358-aff-0001">
<sup>1</sup>
</xref>
          <xref ref-type="aff" rid="embj201798358-aff-0002">
<sup>2</sup>
</xref>
        </contrib>
        <contrib id="embj201798358-cr-0002" contrib-type="author">
          <name>
            <surname>Kolapalli</surname>
            <given-names>Srinivasa Prasad</given-names>
          </name>
          <xref ref-type="aff" rid="embj201798358-aff-0001">
<sup>1</sup>
</xref>
          <xref ref-type="author-notes" rid="embj201798358-note-1001">
<sup>â </sup>
</xref>
        </contrib>
        <contrib id="embj201798358-cr-0003" contrib-type="author">
          <name>
            <surname>Mehto</surname>
            <given-names>Subhash</given-names>
          </name>
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5351-7850</contrib-id>
          <xref ref-type="aff" rid="embj201798358-aff-0001">
<sup>1</sup>
</xref>
          <xref ref-type="author-notes" rid="embj201798358-note-1001">
<sup>â </sup>
</xref>
        </contrib>
        <contrib id="embj201798358-cr-0004" contrib-type="author">
          <name>
            <surname>Nath</surname>
            <given-names>Parej</given-names>
          </name>
          <xref ref-type="aff" rid="embj201798358-aff-0001">
<sup>1</sup>
</xref>
          <xref ref-type="aff" rid="embj201798358-aff-0002">
<sup>2</sup>
</xref>
        </contrib>
        <contrib id="embj201798358-cr-0005" contrib-type="author">
          <name>
            <surname>Das</surname>
            <given-names>Biswajit</given-names>
          </name>
          <xref ref-type="aff" rid="embj201798358-aff-0003">
<sup>3</sup>
</xref>
          <xref ref-type="aff" rid="embj201798358-aff-0004">
<sup>4</sup>
</xref>
        </contrib>
        <contrib id="embj201798358-cr-0006" contrib-type="author">
          <name>
            <surname>Sahoo</surname>
            <given-names>Pradyumna Kumar</given-names>
          </name>
          <xref ref-type="aff" rid="embj201798358-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="embj201798358-cr-0007" contrib-type="author">
          <name>
            <surname>Ahad</surname>
            <given-names>Abdul</given-names>
          </name>
          <xref ref-type="aff" rid="embj201798358-aff-0005">
<sup>5</sup>
</xref>
        </contrib>
        <contrib id="embj201798358-cr-0008" contrib-type="author">
          <name>
            <surname>Syed</surname>
            <given-names>Gulam Hussain</given-names>
          </name>
          <xref ref-type="aff" rid="embj201798358-aff-0006">
<sup>6</sup>
</xref>
        </contrib>
        <contrib id="embj201798358-cr-0009" contrib-type="author">
          <name>
            <surname>Raghav</surname>
            <given-names>Sunil K</given-names>
          </name>
          <xref ref-type="aff" rid="embj201798358-aff-0005">
<sup>5</sup>
</xref>
        </contrib>
        <contrib id="embj201798358-cr-0010" contrib-type="author">
          <name>
            <surname>Senapati</surname>
            <given-names>Shantibhusan</given-names>
          </name>
          <xref ref-type="aff" rid="embj201798358-aff-0003">
<sup>3</sup>
</xref>
        </contrib>
        <contrib id="embj201798358-cr-0011" contrib-type="author">
          <name>
            <surname>Chauhan</surname>
            <given-names>Swati</given-names>
          </name>
          <xref ref-type="aff" rid="embj201798358-aff-0007">
<sup>7</sup>
</xref>
        </contrib>
        <contrib id="embj201798358-cr-0012" contrib-type="author" corresp="yes">
          <name>
            <surname>Chauhan</surname>
            <given-names>Santosh</given-names>
          </name>
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9167-5107</contrib-id>
          <address>
            <email>schauhan@ils.res.in</email>
          </address>
          <xref ref-type="aff" rid="embj201798358-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="embj201798358-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Cell Biology and Infectious Diseases Unit</named-content>
<institution>Institute of Life Sciences</institution>
<named-content content-type="city">Bhubaneswar</named-content>
<country country="IN">India</country>
</aff>
      <aff id="embj201798358-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">School of Biotechnology</named-content>
<institution>KIIT University</institution>
<named-content content-type="city">Bhubaneswar</named-content>
<country country="IN">India</country>
</aff>
      <aff id="embj201798358-aff-0003">
<label><sup>3</sup></label>
<named-content content-type="organisation-division">Tumor Microenvironment and Animal Models</named-content>
<institution>Institute of Life Sciences</institution>
<named-content content-type="city">Bhubaneswar</named-content>
<country country="IN">India</country>
</aff>
      <aff id="embj201798358-aff-0004">
<label><sup>4</sup></label>
<institution>Manipal University</institution>
<named-content content-type="city">Manipal</named-content>
<country country="IN">India</country>
</aff>
      <aff id="embj201798358-aff-0005">
<label><sup>5</sup></label>
<named-content content-type="organisation-division">ImmunoâGenomics and Systems Biology</named-content>
<institution>Institute of Life Sciences</institution>
<named-content content-type="city">Bhubaneswar</named-content>
<country country="IN">India</country>
</aff>
      <aff id="embj201798358-aff-0006">
<label><sup>6</sup></label>
<named-content content-type="organisation-division">Molecular Virology and Infectious Diseases</named-content>
<institution>Institute of Life Sciences</institution>
<named-content content-type="city">Bhubaneswar</named-content>
<country country="IN">India</country>
</aff>
      <aff id="embj201798358-aff-0007">
<label><sup>7</sup></label>
<named-content content-type="organisation-division">Translational Research</named-content>
<institution>Institute of Life Sciences</institution>
<named-content content-type="city">Bhubaneswar</named-content>
<country country="IN">India</country>
</aff>
      <author-notes>
        <corresp id="correspondenceTo"><label>*</label>Corresponding author. Tel: +91 674 2304334; Eâmail: <email>schauhan@ils.res.in</email></corresp>
        <fn fn-type="equal" id="embj201798358-note-1001">
          <label>â </label>
          <p>These authors contributed equally to this work</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub">
        <day>24</day>
        <month>8</month>
        <year>2018</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <day>14</day>
        <month>9</month>
        <year>2018</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>24</day>
        <month>8</month>
        <year>2018</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
      <volume>37</volume>
      <issue>18</issue>
      <issue-id pub-id-type="doi">10.1002/embj.v37.18</issue-id>
      <elocation-id>e98358</elocation-id>
      <history>
        <date date-type="received">
          <day>04</day>
          <month>10</month>
          <year>2017</year>
        </date>
        <date date-type="rev-recd">
          <day>18</day>
          <month>7</month>
          <year>2018</year>
        </date>
        <date date-type="accepted">
          <day>26</day>
          <month>7</month>
          <year>2018</year>
        </date>
      </history>
      <permissions>
        <!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2018 EMBO <copyright-statement>-->
        <copyright-statement content-type="article-copyright">Â© 2018 The Authors. Published under the terms of the CC BY 4.0 license</copyright-statement>
        <license license-type="creativeCommonsBy">
          <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri content-type="pdf" xlink:type="simple" xlink:href="file:EMBJ-37-e98358.pdf"/>
      <abstract id="embj201798358-abs-0001">
        <title>Abstract</title>
        <p>Sequestration of protein aggregates in inclusion bodies and their subsequent degradation prevents proteostasis imbalance, cytotoxicity, and proteinopathies. The underlying molecular mechanisms controlling the turnover of protein aggregates are mostly uncharacterized. Herein, we show that a <styled-content style="fixed-case">TRIM</styled-content> family protein, <styled-content style="fixed-case">TRIM</styled-content>16, governs the process of stressâinduced biogenesis and degradation of protein aggregates. <styled-content style="fixed-case">TRIM</styled-content>16 facilitates protein aggregate formation by positively regulating the p62â<styled-content style="fixed-case">NRF</styled-content>2 axis. We show that <styled-content style="fixed-case">TRIM</styled-content>16 is an integral part of the p62â<styled-content style="fixed-case">KEAP</styled-content>1â<styled-content style="fixed-case">NRF</styled-content>2 complex and utilizes multiple mechanisms for stabilizing <styled-content style="fixed-case">NRF</styled-content>2. Under oxidative and proteotoxic stress conditions, <styled-content style="fixed-case">TRIM</styled-content>16 activates ubiquitin pathway genes and p62 via <styled-content style="fixed-case">NRF</styled-content>2, leading to ubiquitination of misfolded proteins and formation of protein aggregates. We further show that <styled-content style="fixed-case">TRIM</styled-content>16 acts as a scaffold protein and, by interacting with p62, <styled-content style="fixed-case">ULK</styled-content>1, <styled-content style="fixed-case">ATG</styled-content>16L1, and <styled-content style="fixed-case">LC</styled-content>3B, facilitates autophagic degradation of protein aggregates. Thus, <styled-content style="fixed-case">TRIM</styled-content>16 streamlines the process of stressâinduced aggregate clearance and protects cells against oxidative/proteotoxic stressâinduced toxicity <italic>inÂ vitro</italic> and <italic>inÂ vivo</italic>. Taken together, this work identifies a new mechanism of protein aggregate turnover, which could be relevant in protein aggregationâassociated diseases such as neurodegeneration.</p>
      </abstract>
      <kwd-group kwd-group-type="author-generated">
        <kwd id="embj201798358-kwd-0001">autophagy</kwd>
        <kwd id="embj201798358-kwd-0002"><styled-content style="fixed-case">NRF</styled-content>2</kwd>
        <kwd id="embj201798358-kwd-0003">p62</kwd>
        <kwd id="embj201798358-kwd-0004">protein aggregates</kwd>
        <kwd id="embj201798358-kwd-0005"><styled-content style="fixed-case">TRIM</styled-content>16</kwd>
      </kwd-group>
      <kwd-group kwd-group-type="subject-categories">
        <title>Subject Categories</title>
        <kwd>Autophagy &amp; Cell Death</kwd>
        <kwd>Post-translational Modifications, Proteolysis &amp; Proteomics</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>DBT India Alliance (India Alliance)</funding-source>
          <award-id>IA/I/15/2/502071</award-id>
        </award-group>
        <award-group>
          <funding-source>DST|Science and Engineering Research Board (SERB)</funding-source>
          <award-id>ECR/2016/000478</award-id>
          <award-id>PDF/2016/001697</award-id>
        </award-group>
        <award-group>
          <funding-source>Department of Science and Technology, Ministry of Science and Technology (DST)</funding-source>
          <award-id>SR/WOSâA/LSâ9/2016</award-id>
        </award-group>
      </funding-group>
      <counts>
        <fig-count count="14"/>
        <table-count count="0"/>
        <page-count count="23"/>
        <word-count count="16093"/>
      </counts>
      <custom-meta-group>
        <custom-meta>
          <meta-name>source-schema-version-number</meta-name>
          <meta-value>2.0</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>component-id</meta-name>
          <meta-value>embj201798358</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>cover-date</meta-name>
          <meta-value>14 September 2018</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>details-of-publishers-convertor</meta-name>
          <meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:version=5.4.7.1 mode:remove_FC converted:14.09.2018</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
    <notes>
      <p content-type="self-citation">
<mixed-citation publication-type="journal" id="embj201798358-cit-1001">
<source xml:lang="en">The EMBO Journal</source> (<year>2018</year>) <volume>37</volume>: <elocation-id>e98358</elocation-id>
</mixed-citation>
</p>
    </notes>
  </front>
  <body>
    <sec id="embj201798358-sec-0001">
      <title>Introduction</title>
      <p>Misfolded proteins are a common outcome of protein biosynthesis, and about 30% of newly synthesized proteins end up misfolded (Schubert <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0080" ref-type="ref">2000</xref>). Normally, these misfolded proteins are ubiquitinated and degraded by the proteasome system and/or autophagy process (Kraft <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0049" ref-type="ref">2010</xref>; Lamark &amp; Johansen, <xref rid="embj201798358-bib-0052" ref-type="ref">2012</xref>; Amm <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0001" ref-type="ref">2014</xref>; Jackson &amp; Hewitt, <xref rid="embj201798358-bib-0029" ref-type="ref">2016</xref>). Multiple factors ranging from genetic mutations to cellular (oxidative/proteotoxic stress) and environmental stresses can trigger protein misfolding overwhelming the cellular capacity to clear them leading to their aggregation and accumulation (Goldberg, <xref rid="embj201798358-bib-0024" ref-type="ref">2003</xref>; Tyedmers <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0091" ref-type="ref">2010</xref>). Several lines of evidence suggest that formation of protein aggregates is a cytoprotective phenomenon and perturbation in this process results in accumulation of misfolded proteins implicated in many pathological conditions collectively termed as proteinopathies (Alzheimer's, Parkinson's, amyotrophic lateral sclerosis, etc.; Arrasate <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0002" ref-type="ref">2004</xref>; Tanaka <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0090" ref-type="ref">2004</xref>; Douglas <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0019" ref-type="ref">2008</xref>; Tyedmers <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0091" ref-type="ref">2010</xref>). As the unrestrained increase in misfolded proteins is deleterious, the unresolved increase in protein aggregates is also cytotoxic, and clearance of these aggregates increases the cell life span (Komatsu <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0045" ref-type="ref">2006</xref>; Sarkar <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0079" ref-type="ref">2007</xref>; Kirkin <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0043" ref-type="ref">2009</xref>).</p>
      <p>Two types of protein aggregates are documented. The inhibition of the ubiquitinâproteasome system leads to the formation of protein aggregates named as aggresomes (Johnston <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0034" ref-type="ref">1998</xref>; Olzmann <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0070" ref-type="ref">2008</xref>), and exposure to other physiological stresses, such as oxidative stress, protein translation inhibition, and heat shock, results in the formation of another kind of protein aggregates termed as ALIS (aggresomeâlike induced structures; Szeto <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0088" ref-type="ref">2006</xref>). The formation of aggresomes but not of ALIS is dependent on microtubules and dynein motors (Johnston <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0035" ref-type="ref">2002</xref>; Szeto <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0088" ref-type="ref">2006</xref>). Both types of protein aggregates are considered to be degraded by selective autophagy, termed as aggrephagy (Kirkin <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0043" ref-type="ref">2009</xref>). The defects in autophagy lead to the accumulation of protein aggregates and have been linked to severity of several proteinopathies and neuropathies (Hara <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0025" ref-type="ref">2006</xref>; Komatsu <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0045" ref-type="ref">2006</xref>, <xref rid="embj201798358-bib-0047" ref-type="ref">2007b</xref>; Yao, <xref rid="embj201798358-bib-0096" ref-type="ref">2010</xref>).</p>
      <p>NRF2 (nuclear factor erythroid 2ârelated factor 2) is a key transcription factor that drives the cellular response to combat a variety of stresses including oxidative stress, proteotoxic stress and electrophilic insults (Takaya <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0089" ref-type="ref">2012</xref>; Jaramillo &amp; Zhang, <xref rid="embj201798358-bib-0031" ref-type="ref">2013</xref>; Kansanen <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0036" ref-type="ref">2013</xref>). Under basal conditions, KEAP1 (Kelchâlike ECHâassociated protein 1) interacts with NRF2 and mediates its degradation (Kansanen <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0036" ref-type="ref">2013</xref>). Exposure of cell to oxidative stress and electrophilic insult inactivate KEAP1 leading to the nuclear translocation of stable NRF2 followed by transcriptional induction of cytoprotective and antioxidant response genes (Motohashi &amp; Yamamoto, <xref rid="embj201798358-bib-0063" ref-type="ref">2004</xref>). Multiple studies have shown the role of autophagy adaptor protein p62/SQSTM1 (sequestosome 1, hereafter referred to as p62) in positive regulation of NRF2 by either interfering with NRF2âKEAP1 interaction or facilitating the sequestration and autophagic degradation of KEAP1 (Copple <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0015" ref-type="ref">2010</xref>; Jain <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0030" ref-type="ref">2010</xref>; Komatsu <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0048" ref-type="ref">2010</xref>; Riley <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0077" ref-type="ref">2011</xref>). Subsequently, the free NRF2 translocates to the nucleus and upregulates expression of antioxidant response element (ARE) containing genes such as <italic>Hmox1</italic>,<italic> Nqo1,</italic> and <italic>p62</italic> (Copple <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0015" ref-type="ref">2010</xref>; Jain <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0030" ref-type="ref">2010</xref>; Komatsu <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0048" ref-type="ref">2010</xref>; Lau <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0055" ref-type="ref">2010</xref>). As a positive feedback mechanism, p62 stabilizes NRF2 leading to further amplification of the NRF2 response (Jain <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0030" ref-type="ref">2010</xref>). The p62 is implicated in both assembly and degradation of protein aggregates (Komatsu <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0047" ref-type="ref">2007b</xref>; Pankiv <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0072" ref-type="ref">2007</xref>; Nezis <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0067" ref-type="ref">2008</xref>). It interacts with ubiquitin over the misfolded proteins, and due to its capacity to selfâpolymerize, it facilitates the formation of protein aggregates (Nagaoka <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0064" ref-type="ref">2004</xref>; Seibenhener <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0083" ref-type="ref">2004</xref>; Bjorkoy <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0008" ref-type="ref">2005</xref>, <xref rid="embj201798358-bib-0009" ref-type="ref">2006</xref>). Subsequently, p62 interacts with LC3B and targets protein aggregates to autophagic degradation (Bjorkoy <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0009" ref-type="ref">2006</xref>).</p>
      <p>The ubiquitin system plays a crucial role in formation and degradation of protein aggregates (Dodson <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0018" ref-type="ref">2015</xref>). The chronological actions of three enzymes catalyze the process of protein ubiquitination: ubiquitinâactivating enzymes, ubiquitinâconjugating enzymes, and ubiquitin ligases, known as E1s, E2s, and E3s. The proteotoxic and oxidative stresses disrupt protein homeostasis leading to increase ubiquitinâtagged misfolded proteins which subsequently form protein aggregates.</p>
      <p>Tripartite motif (TRIM) proteins are a family of about 75 proteins with E3 ligase activities and with varied functions in cellular processes, including innate immunity, cell proliferation, differentiation, development, carcinogenesis, apoptosis, and autophagy (Nisole <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0068" ref-type="ref">2005</xref>; Hatakeyama, <xref rid="embj201798358-bib-0026" ref-type="ref">2017</xref>). Several of the TRIM proteins are shown to function as autophagy regulatorâreceptor and modulate the selective autophagy process (Mandell <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0059" ref-type="ref">2014a</xref>,<xref rid="embj201798358-bib-0060" ref-type="ref">b</xref>; Kimura <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0038" ref-type="ref">2015</xref>, <xref rid="embj201798358-bib-0039" ref-type="ref">2016a</xref>,<xref rid="embj201798358-bib-0040" ref-type="ref">b</xref>; Chauhan <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0011" ref-type="ref">2016</xref>). TRIMs are shown to form a platform for the assembly of core autophagic machinery, including autophagy initiation (ULK1), elongation (ATG16L1), and completion (LC3B) factors and facilitate the interaction of the autophagic machinery with the specific autophagic cargo. In a previous study, we have shown that TRIM16 interacts with galectinâ3 and recognizes damaged endomembranes leading to the assembly of autophagy machinery for selective sequestration of damaged lysosomes and phagosomes (Chauhan <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0011" ref-type="ref">2016</xref>). More recently, TRIM16 is shown to play a role in secretory autophagy where it interacts with SNARE proteins to recruit cargoes to autophagosomes (Kimura <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0040" ref-type="ref">2016b</xref>).</p>
      <p>In this study, we show that under oxidative or proteotoxic stress conditions, an intricate positive feedback loop involving TRIM16, NRF2, KEAP1, and p62 direct the formation of protein aggregates from misfolded proteins. TRIM16 regulates expression and stability of NRF2, KEAP1, and p62. For the first time, this study underscores the role of NRF2 in protein aggregate formation. Furthermore, we show that TRIM16 also drives the autophagic degradation of the protein aggregates. TRIM16 performs a comprehensive role in protein aggregates turnover to safeguard the cells from stressâinduced highly toxic misfolded proteins both <italic>inÂ vitro</italic> and <italic>inÂ vivo</italic>.</p>
    </sec>
    <sec id="embj201798358-sec-0002">
      <title>Results</title>
      <sec id="embj201798358-sec-0003">
        <title>TRIM16 is required for biogenesis of aggresomes/ALIS</title>
        <p>Previous studies indicate that TRIM16 is an oxidative stressâinduced gene (Noguchi, <xref rid="embj201798358-bib-0069" ref-type="ref">2008</xref>; Python <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0074" ref-type="ref">2009</xref>; Hirose <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0027" ref-type="ref">2011</xref>). Given the role of TRIM proteins including TRIM16 in selective autophagy (Mandell <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0059" ref-type="ref">2014a</xref>,<xref rid="embj201798358-bib-0060" ref-type="ref">b</xref>, <xref rid="embj201798358-bib-0061" ref-type="ref">2016</xref>; Kimura <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0038" ref-type="ref">2015</xref>, <xref rid="embj201798358-bib-0039" ref-type="ref">2016a</xref>,<xref rid="embj201798358-bib-0040" ref-type="ref">b</xref>, <xref rid="embj201798358-bib-0041" ref-type="ref">2017a</xref>,<xref rid="embj201798358-bib-0042" ref-type="ref">b</xref>; Chauhan <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0011" ref-type="ref">2016</xref>; Fraiberg &amp; Elazar, <xref rid="embj201798358-bib-0021" ref-type="ref">2016</xref>; Kumar <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0050" ref-type="ref">2017</xref>), we envisaged the role of TRIM16 in autophagic degradation of protein aggregates (aggrephagy) formed during oxidative or proteotoxic stress conditions. The protein aggregates can be scored by immunofluorescence using antiâubiquitin antibody (Kirkin <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0043" ref-type="ref">2009</xref>; Lamark &amp; Johansen, <xref rid="embj201798358-bib-0052" ref-type="ref">2012</xref>; Svenning &amp; Johansen, <xref rid="embj201798358-bib-0087" ref-type="ref">2013</xref>; Lystad &amp; Simonsen, <xref rid="embj201798358-bib-0058" ref-type="ref">2015</xref>). If TRIM16 mediates the degradation of ubiquitinated protein aggregates, ubiquitin (hereafter, Ub) dots should accumulate in TRIM16âdepleted cells. Surprisingly, as compared to control cells, the TRIM16 CRISPRâCAS9 knockout (hereafter TRIM16<sup>KO</sup>; <xref rid="embj201798358-sup-0001" ref-type="supplementary-material">AppendixÂ Fig S1A</xref>) or siRNA knockdown cells (<xref rid="embj201798358-sup-0001" ref-type="supplementary-material">AppendixÂ Fig S1B and C</xref>) showed substantially reduced levels of Ub dots formed under oxidative (H<sub>2</sub>O<sub>2</sub>) or proteotoxic stress conditions (MG132, puromycin) (FigÂ <xref rid="embj201798358-fig-0001ev" ref-type="fig">EV1</xref>AâC, <xref rid="embj201798358-sup-0001" ref-type="supplementary-material">AppendixÂ Fig S1D and E</xref>). In the case of puromycin treatment, the difference was observed in size (smaller) and numbers of Ub dots per cells (FigÂ <xref rid="embj201798358-fig-0001ev" ref-type="fig">EV1</xref>A and C) but not in the number of cells with Ub dots (FigÂ <xref rid="embj201798358-fig-0001ev" ref-type="fig">EV1</xref>B). The TRIM16<sup>KO</sup> HeLa cells were described previously (Chauhan <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0011" ref-type="ref">2016</xref>; <xref rid="embj201798358-sup-0001" ref-type="supplementary-material">AppendixÂ Fig S1A</xref>).</p>
        <fig fig-type="Figure" xml:lang="en" specific-use="collapsible" id="embj201798358-fig-0001ev" orientation="portrait" position="float">
          <label>Figure EV1</label>
          <caption>
            <title>
<styled-content style="fixed-case">TRIM</styled-content>16 is important for assembly of the protein aggregates</title>
            <p>
<list list-type="simple" id="embj201798358-list-0011"><list-item><label>A</label><p>Confocal images of HeLa and TRIM16<sup>KO</sup> cells, untreated or treated with MG132 (20Â Î¼M, 2Â h), H<sub>2</sub>O<sub>2</sub> (200Â Î¼M, 2Â h), and puromycin (5Â Î¼g/ml, 2Â h), and processed for immunofluorescence (IF) analysis with ubiquitin (FK2) antibody.</p></list-item><list-item><label>B</label><p>HeLa and TRIM16<sup>KO</sup> cells were visualized, and cells with more than two visible aggresomes/ALIS were considered positive. MeanÂ Â±Â SD, <italic>n</italic>Â =Â 3, **<italic>P</italic>Â &lt;Â 0.005 (Student's unpaired <italic>t</italic>âtest).</p></list-item><list-item><label>C</label><p>Total numbers of visible Ub puncta in each cell were counted and plotted. Data are from â¥Â 10 microscopic fields for each condition, <italic>n</italic>Â =Â 3, meanÂ Â±Â SD, *<italic>P</italic>Â &lt;Â 0.05 (Student's unpaired <italic>t</italic>âtest).</p></list-item><list-item><label>D</label><p>Representative confocal images of control siRNA and TRIM16 siRNA transfected cells treated with puromycin (5Â Î¼g/ml, 2Â h), where IF analysis was conducted with Ub and p62 antibodies.</p></list-item><list-item><label>E</label><p>The graph shows the average number of Ubâp62 coâlocalized aggregates per cell from the experiment in panel (D). MeanÂ Â±Â SD, <italic>n</italic>Â =Â 3, *<italic>P</italic>Â &lt;Â 0.05 (Student's unpaired <italic>t</italic>âtest).</p></list-item><list-item><label>F</label><p>Representative confocal images of HeLa and TRIM16<sup>KO</sup> cells treated with As<sub>2</sub>O<sub>3</sub> (2.5Â Î¼M, 2Â h), where IF analysis was conducted with Ub and p62 antibodies. Right panel: Fluorescence intensity line is tracing corresponding to a white line in zoom panel.</p></list-item><list-item><label>G, H</label><p>Representative confocal images of HeLa and TRIM16<sup>KO</sup> cells treated with (G) MG132 (20Â Î¼M, 2Â h) or (H) H<sub>2</sub>O<sub>2</sub> (200Â Î¼M, 2Â h) and processed for IF analysis with Ub and LC3B antibody.</p></list-item><list-item><label>I</label><p>WB analysis of LC3B levels in lysates of cells transfected with control vector or FlagâTRIM16.</p></list-item><list-item><label>J</label><p>Densitometric analysis of WB normalized with actin. MeanÂ Â±Â SD, *<italic>P</italic>Â &lt;Â 0.05 (Student's unpaired <italic>t</italic>âtest), <italic>n</italic>Â =Â 3.</p></list-item><list-item><label>K</label><p>Representative confocal images HeLa and TRIM16<sup>KO</sup> cells treated with H<sub>2</sub>O<sub>2</sub> (200Â Î¼M, 2Â h) and processed for IF analysis with ProteoStat dye and p62 antibody.</p></list-item></list>Data information: Unless otherwise stated, scale bar: 10Â Î¼m.<named-content content-type="attribution">Source data are available online for this figure.</named-content>
</p>
          </caption>
          <graphic id="nlm-graphic-5" xlink:href="EMBJ-37-e98358-g003"/>
        </fig>
        <p>The p62 protein interacts with ubiquitinated misfolded proteins and promotes aggresomes/ALIS formation (Seibenhener <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0083" ref-type="ref">2004</xref>; Bjorkoy <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0009" ref-type="ref">2006</xref>; Johansen &amp; Lamark, <xref rid="embj201798358-bib-0033" ref-type="ref">2011</xref>). We next analyzed the status of Ubâp62 doubleâpositive ALIS/aggresomes formed during oxidative (H<sub>2</sub>O<sub>2</sub> and As<sub>2</sub>O<sub>3</sub>) or proteotoxic stress (MG132 and puromycin) conditions. As compared to control cells, TRIM16âdepleted cells (TRIM16<sup>KO</sup> or TRIM16âsiRNA) formed substantially reduced Ubâp62 doubleâpositive aggresomes/ALIS (FigsÂ <xref rid="embj201798358-fig-0001" ref-type="fig">1</xref>AâF and <xref rid="embj201798358-fig-0001ev" ref-type="fig">EV1</xref>DâF). Aggresomes are present in the detergentâinsoluble fraction of the cell lysate (Lystad &amp; Simonsen, <xref rid="embj201798358-bib-0058" ref-type="ref">2015</xref>). Next, we analyzed the status of aggresomes by Western blotting the detergentâsoluble and detergentâinsoluble cell fractions. The polyâubiquitination of soluble proteins and soluble p62 was slightly lower in TRIM16<sup>KO</sup> cells compared to control cells (FigÂ <xref rid="embj201798358-fig-0001" ref-type="fig">1</xref>GâI). However, there was a substantial reduction in insoluble (aggresomeâenriched) polyâUb or p62 in TRIM16<sup>KO</sup> cells compared to control cells (FigÂ <xref rid="embj201798358-fig-0001" ref-type="fig">1</xref>GâI).</p>
        <fig fig-type="Figure" xml:lang="en" id="embj201798358-fig-0001" orientation="portrait" position="float">
          <label>Figure 1</label>
          <caption>
            <title>TRIM16 is required for assembly of protein aggregates</title>
            <p>
<list list-type="simple" id="embj201798358-list-0002"><list-item><label>AâF</label><p>(A, D) Representative confocal images of HeLa and TRIM16<sup>KO</sup> cells treated with (A) MG132 (20Â Î¼M, 2Â h, scale bar: 7.5Â Î¼m) or (D) H<sub>2</sub>O<sub>2</sub> (200Â Î¼M, 2Â h) and the samples were processed for IF analysis with Ub and p62 antibody. (B, E) Representative confocal images of control siRNA and TRIM16 siRNA transfected cells treated with (B) MG132 (20Â Î¼M, 2Â h), (E) H<sub>2</sub>O<sub>2</sub>, (200Â Î¼M, 2Â h), where IF analysis was conducted with Ub and p62 antibodies. (C, F) The graph shows the percentage of cells with Ubâp62 coâlocalized dots. Data from â¥Â 10 fields (40Ã), <italic>n</italic>Â =Â 3, meanÂ Â±Â SD, **<italic>P</italic>Â &lt;Â 0.0003, *<italic>P</italic>Â &lt;Â 0.002 (Student's unpaired <italic>t</italic>âtest).</p></list-item><list-item><label>G</label><p>Western blot (WB) analysis of detergentâsoluble and detergentâinsoluble fractions of HeLa and TRIM16<sup>KO</sup> cells treated with MG132 (50Â Î¼M, 1Â h) and probed with indicated antibodies.</p></list-item><list-item><label>H, I</label><p>Densitometric analysis (using ImageJ) of WB normalized with Î±âtubulin or laminâB1.</p></list-item><list-item><label>J</label><p>Representative confocal images of HeLa and TRIM16<sup>KO</sup> cells treated with MG132 (20Â Î¼M, 2Â h) and processed for IF analysis with Ub and LC3B antibody.</p></list-item><list-item><label>K, L</label><p>WB analysis of LC3B levels in lysates of HeLa and TRIM16<sup>KO</sup> cells treated with (K) bafilomycin A1 (300Â nM, 3Â h) alone or (L) with MG132 (10Â Î¼M, 4Â h) as indicated. L.E, low exposure; H.E, high exposure.</p></list-item><list-item><label>M</label><p>Representative confocal images HeLa and TRIM16<sup>KO</sup> cells treated with H<sub>2</sub>O<sub>2</sub> (200Â Î¼M, 2Â h) and processed for IF analysis with ProteoStat dye, and p62 antibody. To show the cellular details, the brightness of TRIM16<sup>KO</sup> cells images was increased more than control cells.</p></list-item><list-item><label>N</label><p>Pictorial representation of data presented in FigsÂ <xref rid="embj201798358-fig-0001" ref-type="fig">1</xref> and <xref rid="embj201798358-fig-0001ev" ref-type="fig">EV1</xref>.</p></list-item></list>Data information: Unless otherwise stated, scale bar: 10Â Î¼m.<named-content content-type="attribution">Source data are available online for this figure.</named-content>
</p>
          </caption>
          <graphic id="nlm-graphic-7" xlink:href="EMBJ-37-e98358-g002"/>
        </fig>
        <p>LC3B is a marker protein for autophagosomes (Klionsky <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0044" ref-type="ref">2016</xref>). p62 binds to ubiquitinated misfolded proteins and recruits LC3B leading to the autophagyâmediated degradation of ubiquitinated proteins/protein aggregates (Vadlamudi <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0092" ref-type="ref">1996</xref>; Pankiv <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0072" ref-type="ref">2007</xref>). Since Ubâp62 doubleâpositive dots were substantially reduced in TRIM16âdepleted cells, we next analyzed the status of LC3B. We found that the oxidative and proteotoxic stressâinduced UbâLC3B doubleâpositive dots were also significantly reduced in TRIM16âdepleted cells as compared to the control cells (FigsÂ <xref rid="embj201798358-fig-0001" ref-type="fig">1</xref>J and <xref rid="embj201798358-fig-0001ev" ref-type="fig">EV1</xref>G and H).</p>
        <p>Two alternative hypotheses were tested to understand the reason for fewer Ubâp62 or UbâLC3B dots in TRIM16âdepleted cells. The first hypothesis was that TRIM16 is a negative regulator of autophagy, and therefore, enhanced autophagy in TRIM16âdepleted cells leads to rapid degradation of the aggregated proteins resulting in lesser Ub/p62/LC3B dots in the cells. To test this hypothesis, the status of autophagy was scrutinized in TRIM16âdepleted cells using LC3B marker protein. We observed that basal and MG132âinduced autophagy flux was attenuated in TRIM16<sup>KO</sup> cells compared to the control cells (FigÂ <xref rid="embj201798358-fig-0001" ref-type="fig">1</xref>KâL). Conversely, overexpression of TRIM16 increased the LC3B levels in HEK293T cells (FigÂ <xref rid="embj201798358-fig-0001ev" ref-type="fig">EV1</xref>I and J). These data show that TRIM16 is a positive regulator of autophagy process, and thus, reduction in Ub/p62/LC3B dots in TRIM16âdepleted cells is not due to enhanced autophagic flux.</p>
        <p>The second hypothesis we tested was that a lesser number of aggresomes/ALIS are formed in TRIM16âdepleted cells, leading to reduced number of Ubâp62 and UbâLC3B dots. To evaluate this hypothesis, we employed an extensively used protein aggregates specific molecular rotor dye named as ProteoStat (Shen <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0086" ref-type="ref">2011</xref>; Bershtein <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0005" ref-type="ref">2013</xref>; Navarro &amp; Ventura, <xref rid="embj201798358-bib-0065" ref-type="ref">2014</xref>; Seo <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0085" ref-type="ref">2016</xref>), which binds to the tertiary structure of aggregated proteins and emits red fluorescence. H<sub>2</sub>O<sub>2</sub>âtreated HeLa cells showed red fluorescent protein aggregates which completely coâlocalize with p62, whereas TRIM16<sup>KO</sup> cells were almost devoid of protein aggregates (FigsÂ <xref rid="embj201798358-fig-0001" ref-type="fig">1</xref>M and <xref rid="embj201798358-fig-0001ev" ref-type="fig">EV1</xref>K, <xref rid="embj201798358-sup-0001" ref-type="supplementary-material">AppendixÂ Fig S1F</xref>) showing that TRIM16 is important for biogenesis of protein aggregates. Taken together, the evidence suggests that TRIM16 is required for the assembly of protein aggregates (FigÂ <xref rid="embj201798358-fig-0001" ref-type="fig">1</xref>N).</p>
      </sec>
      <sec id="embj201798358-sec-0004">
        <title>TRIM16 regulates the p62âKEAP1âNRF2 system</title>
        <p>Next, we investigated the molecular mechanism/s by which TRIM16 mediates biogenesis of protein aggregates. The p62 is known to play a vital role in the biogenesis of protein aggregates (Komatsu <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0047" ref-type="ref">2007b</xref>). It regulates NRF2 which play a critical role in proteostasis and redox homeostasis (Komatsu <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0048" ref-type="ref">2010</xref>; Lau <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0055" ref-type="ref">2010</xref>; Kansanen <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0036" ref-type="ref">2013</xref>; Wang <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0093" ref-type="ref">2013</xref>; Pajares <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0071" ref-type="ref">2017</xref>). We observed diminished levels of p62 in TRIM16âdepleted cells (FigÂ <xref rid="embj201798358-fig-0002" ref-type="fig">2</xref>A, <xref rid="embj201798358-sup-0001" ref-type="supplementary-material">AppendixÂ Fig S2A</xref>) and the overexpression of TRIM16 resulted in increased p62 levels (FigÂ <xref rid="embj201798358-fig-0001ev" ref-type="fig">EV1</xref>A) suggesting that TRIM16 positively regulates p62 expression. Phosphorylation of p62 at serine 349 (in human) is indispensable for the p62âmediated NRF2âactivation (Ichimura <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0028" ref-type="ref">2013</xref>). The phosphorylation of p62 (S349) is increased on the treatment with MG132 in control cells but not in TRIM16<sup>KO</sup> cells indicating that TRIM16 is important for phosphorylation of p62 at S349 (FigÂ <xref rid="embj201798358-fig-0002" ref-type="fig">2</xref>B). We next determined the levels of NRF2 in cells with altered expression of TRIM16. NRF2 levels (cytoplasmic and nuclear) were substantially less in TRIM16<sup>KO</sup> cells compared to the control cells (FigsÂ <xref rid="embj201798358-fig-0002" ref-type="fig">2</xref>C and <xref rid="embj201798358-fig-0002ev" ref-type="fig">EV2</xref>B), whereas overexpression of TRIM16 significantly increased the NRF2 levels (FigÂ <xref rid="embj201798358-fig-0002" ref-type="fig">2</xref>D and E) indicating that TRIM16 positively regulates NRF2 expression too. On the contrary, KEAP1 expression was high in TRIM16âdepleted cells, and its levels were decreased on overexpression of TRIM16 (FigÂ <xref rid="embj201798358-fig-0002" ref-type="fig">2</xref>F and G, <xref rid="embj201798358-sup-0001" ref-type="supplementary-material">AppendixÂ Fig S2B and C</xref>) suggesting a negative regulation.</p>
        <fig fig-type="Figure" xml:lang="en" id="embj201798358-fig-0002" orientation="portrait" position="float">
          <label>Figure 2</label>
          <caption>
            <title>
<styled-content style="fixed-case">TRIM</styled-content>16 regulates the p62â<styled-content style="fixed-case">KEAP</styled-content>1â<styled-content style="fixed-case">NRF</styled-content>2 system</title>
            <p>
<list list-type="simple" id="embj201798358-list-0003"><list-item><label>A</label><p>Western blot analysis of HeLa and TRIM16<sup>KO</sup> cell lysates probed with indicated antibodies.</p></list-item><list-item><label>B</label><p>Western blot analysis of lysates from HeLa and TRIM16<sup>KO</sup> cells treated with or without MG132 and probed with indicated antibodies.</p></list-item><list-item><label>C</label><p>Left panel, Western blotting with HeLa and TRIM16<sup>KO</sup> cell lysates probed with indicated antibodies. Right panel, densitometric analysis (meanÂ Â±Â SD) of protein band intensity relative to actin, <italic>n</italic>Â =Â 3, ***<italic>P</italic>Â &lt;Â 0.0005 (Student's unpaired <italic>t</italic>âtest).</p></list-item><list-item><label>DâG</label><p>(D, F) HEK293T cells were either transiently transfected with an empty vector or a FlagâtaggedâTRIM16 expressing vector and immunoblotted with Flag or indicated antibodies. L.E, low exposure; H.E, high exposure. (E, G) Densitometric analysis (meanÂ Â±Â SD) of protein band intensity relative to actin, <italic>n</italic>Â =Â 3, *<italic>P</italic>Â &lt;Â 0.05 (Student's unpaired <italic>t</italic>âtest).</p></list-item><list-item><label>H</label><p>WB analysis of HeLa and TRIM16<sup>KO</sup> lysates of cells treated with cycloheximide (100Â Î¼g/ml) for the indicated period and probed with different antibodies as indicated. The blots of control and TRIM16<sup>KO</sup> cells are exposed for the equal duration and developed together on the same Xâray film.</p></list-item><list-item><label>I</label><p>Quantification of NRF2, p62, and KEAP1 band intensities relative to actin. <italic>n</italic>Â =Â 3, **<italic>P</italic>Â &lt;Â 0.005, *<italic>P</italic>Â &lt;Â 0.05 (Student's unpaired <italic>t</italic>âtest).</p></list-item><list-item><label>J</label><p>Immunoprecipitation (IP) analysis of interaction between endogenous TRIM16 and endogenous p62 in HeLa cell lysates in absence and presence of MG132 (10Â Î¼M, 4Â h). *The panel (J) here, FigÂ <xref rid="embj201798358-fig-0002ev" ref-type="fig">EV2</xref>H, and <xref rid="embj201798358-sup-0001" ref-type="supplementary-material">AppendixÂ Fig S3H</xref> are part of same blots; hence, the input for TRIM16 is same.</p></list-item><list-item><label>K</label><p>The domain organization map of TRIM16 and deletion constructs cloned as Mycâtagged proteins.</p></list-item><list-item><label>L, M</label><p>IP analysis to map the interaction between p62 and TRIM16 domains in HEK293T cell lysates in (L) absence and (M) presence of MG132 (10Â Î¼M, 4Â h).</p></list-item><list-item><label>N</label><p>IP analysis of the interaction between endogenous TRIM16 and endogenous NRF2 in HeLa cell lysates. M<sup>r</sup>, molecular weight marker.</p></list-item><list-item><label>O</label><p>CoâIP analysis to map the interaction between NRF2 and TRIM16 domains in HEK293T cell lysates.</p></list-item><list-item><label>P</label><p>IP analysis of the interaction between endogenous TRIM16 and endogenous KEAP1 in HeLa cell lysates.</p></list-item></list>
</p>
            <p>
<named-content content-type="attribution">Source data are available online for this figure.</named-content>
</p>
          </caption>
          <graphic id="nlm-graphic-9" xlink:href="EMBJ-37-e98358-g004"/>
        </fig>
        <fig fig-type="Figure" xml:lang="en" specific-use="collapsible" id="embj201798358-fig-0002ev" orientation="portrait" position="float">
          <label>Figure EV2</label>
          <caption>
            <title>
<styled-content style="fixed-case">TRIM</styled-content>16 interacts with and regulates the expression of p62, <styled-content style="fixed-case">KEAP</styled-content>1, and <styled-content style="fixed-case">NRF</styled-content>2</title>
            <p>
<list list-type="alpha-upper" id="embj201798358-list-0012"><list-item><p>Left panel, HEK293T cells were either transiently transfected with an empty vector or a FlagâtaggedâTRIM16 expressing vector and immunoblotted with Flag or indicated antibodies. Right panel, densitometric analysis (meanÂ Â±Â SD) of protein band intensity relative to actin, <italic>n</italic>Â =Â 3, *<italic>P</italic>Â &lt;Â 0.05 (Student's unpaired <italic>t</italic>âtest).</p></list-item><list-item><p>Western blot analysis of cytoplasmic and nuclear fraction isolated from MG132âtreated control and TRIM16<sup>KO</sup> cells.</p></list-item><list-item><p>WB analysis of HeLa and TRIM16<sup>KO</sup> lysates of cells treated with cycloheximide (100Â Î¼g/ml) for the indicated period and probed with different antibodies as indicated. The blots of control and TRIM16<sup>KO</sup> cells are exposed for the equal duration and developed together on the same Xâray film.</p></list-item><list-item><p>WB analysis of control or FlagâTRIM16 vector transfected HeLa cells treated with cycloheximide (100Â Î¼g/ml) for the indicated period and probed with different antibodies as indicated. The blots of control and overexpressed cells are exposed for the equal duration and developed together on the same Xâray film.</p></list-item><list-item><p>Quantification of KEAP1, p62, and NRF2 band intensities (from panel D) relative to actin.</p></list-item><list-item><p>CoâIP analysis of the interaction between TRIM16 and NRF2 in HEK293T lysates of cells expressing GFP or GFPâNRF2 and FlagâTRIM16.</p></list-item><list-item><p>CoâIP analysis of the interaction between TRIM16 and KEAP1 in HEK293T lysates of cells expressing vector control or FlagâTRIM16 and GFPâKEAP1.</p></list-item><list-item><p>IP analysis of the interaction between endogenous TRIM16 and endogenous KEAP1 in HeLa cell lysates in absence and presence of MG132. *The panel (H) here, FigÂ <xref rid="embj201798358-fig-0002" ref-type="fig">2</xref>J, and <xref rid="embj201798358-sup-0001" ref-type="supplementary-material">AppendixÂ Fig S3H</xref> are part of same blots; hence, the input for TRIM16 is same.</p></list-item></list>
</p>
            <p>
<named-content content-type="attribution">Source data are available online for this figure.</named-content>
</p>
          </caption>
          <graphic id="nlm-graphic-11" xlink:href="EMBJ-37-e98358-g005"/>
        </fig>
        <p>Next, we asked whether TRIM16 regulates p62, NRF2, and KEAP1 expression at mRNA or protein levels. No significant change in the mRNA levels of <italic>Nrf2</italic> and <italic>Keap1</italic> was observed in TRIM16<sup>KO</sup> cells in comparison with control cells, whereas a small but significant reduction was detected in <italic>p62</italic> mRNA expression (<xref rid="embj201798358-sup-0001" ref-type="supplementary-material">AppendixÂ Fig S2D</xref>). Next, we performed cycloheximide chase experiments to explore the role of TRIM16 in stabilizing NRF2, p62 and KEAP1 proteins. Both TRIM16 depletion and the overexpression experiments show that TRIM16 stabilizes NRF2 and p62 whereas destabilizes the KEAP1 (FigsÂ <xref rid="embj201798358-fig-0002" ref-type="fig">2</xref>H and I, and <xref rid="embj201798358-fig-0002ev" ref-type="fig">EV2</xref>CâE). Altogether, the results suggest that TRIM16 regulates NRF2 and KEAP1 at the protein level, whereas it regulates p62 at both protein and mRNA levels.</p>
        <p>Next, we investigated whether TRIM16 interacts and is part of p62, NRF2, and KEAP1 complex. The p62 interacts with TRIM16 weakly under basal conditions, and the interaction was increased significantly under the proteotoxic stress conditions (FigÂ <xref rid="embj201798358-fig-0002" ref-type="fig">2</xref>J). These data are in agreement with the previous study where TRIM16âp62 direct interaction was found to be weak in <italic>inÂ vitro</italic> conditions (Mandell <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0059" ref-type="ref">2014a</xref>). This increased interaction may take place over the aggresomes where TRIM16 and p62 strongly coâlocalizes (see below, Fig <xref rid="embj201798358-fig-0007" ref-type="fig">7</xref>E). Next, we determined the specificity of TRIM16âp62 interaction by mapping the domains of TRIM16 required for the interaction with p62 under both, basal and proteotoxic stress conditions. TRIM16 contains two B box, one CCD, and one SPRY domain/s (FigÂ <xref rid="embj201798358-fig-0002" ref-type="fig">2</xref>K). TRIM16 B box domains are shown to be important for its E3 ligase activity and CCD domain help in homodimerization or heterodimerization with other TRIM proteins (Bell <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0004" ref-type="ref">2012</xref>). The SPRY domain of TRIM proteins is known to mediate proteinâprotein interactions (Marin, <xref rid="embj201798358-bib-0062" ref-type="ref">2012</xref>; D'Cruz <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0017" ref-type="ref">2013</xref>). Under basal or proteotoxic stress conditions, the SPRY domain deleted TRIM16 protein (containing B1/B2 box and CCD domain) was not able to interact with p62 suggesting that SPRY domain is required for TRIM16âp62 interaction (FigÂ <xref rid="embj201798358-fig-0002" ref-type="fig">2</xref>L and M). In agreement with this notion, the SPRY domain alone can interact with p62 (FigÂ <xref rid="embj201798358-fig-0002" ref-type="fig">2</xref>L and M). The B1/B2 box deleted TRIM16 (containing SPRY and CCD domain) interacted with p62 stronger than wildâtype protein, suggesting that B1/B2 boxes may hinder the TRIM16âp62 interaction (FigÂ <xref rid="embj201798358-fig-0002" ref-type="fig">2</xref>L and M). This could be a regulatory mechanism to avoid unspecific interaction in the absence of stimulation.</p>
        <p>Endogenous NRF2 strongly interacted with TRIM16 under basal conditions (FigÂ <xref rid="embj201798358-fig-0002" ref-type="fig">2</xref>N), and this interaction was lost under proteotoxic stress conditions (<xref rid="embj201798358-sup-0001" ref-type="supplementary-material">AppendixÂ Fig S2E</xref>). The MG132 treatment (proteotoxic stress) is known to cause translocation of NRF2 to the nucleus (Sahni <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0078" ref-type="ref">2008</xref>; Cui <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0016" ref-type="ref">2013</xref>). However, TRIM16 remains cytoplasmic in these conditions (refer to Fig <xref rid="embj201798358-fig-0007" ref-type="fig">7</xref>E). This may provide an explanation for the loss of TRIM16âNRF2 interaction after MG132 treatment. Coâimmunoprecipitation assays with overexpressed proteins also revealed a strong interaction between TRIM16 and NRF2 (FigÂ <xref rid="embj201798358-fig-0002ev" ref-type="fig">EV2</xref>F, <xref rid="embj201798358-sup-0001" ref-type="supplementary-material">AppendixÂ Fig S2F</xref>). Next, we mapped domain/s of TRIM16 required for interaction with NRF2. The deletion of SPRY domain completely abolished the interaction between TRIM16 and NRF2 (FigÂ <xref rid="embj201798358-fig-0002" ref-type="fig">2</xref>O). Also, the TRIM16 SPRY domain alone can efficiently interact with NRF2 suggesting that like in case of p62, SPRY domain of TRIM16 is crucial for its interaction with NRF2 (FigÂ <xref rid="embj201798358-fig-0002" ref-type="fig">2</xref>O). We found that TRIM16 also associates with KEAP1 (FigsÂ <xref rid="embj201798358-fig-0002" ref-type="fig">2</xref>P and <xref rid="embj201798358-fig-0002ev" ref-type="fig">EV2</xref>G) and this interaction was unchanged under proteotoxic stress conditions (FigÂ <xref rid="embj201798358-fig-0002ev" ref-type="fig">EV2</xref>H).</p>
        <p>Next, we sought to determine the reason for the TRIM16âmediated stability of NRF2. As described above, KEAP1 is a negative regulator of NRF2 stability. We found that TRIM16 displaces KEAP1 from NRF2 (FigÂ <xref rid="embj201798358-fig-0003" ref-type="fig">3</xref>A and B). The p62 on the other hand increases the stability of NRF2. We found that TRIM16 enhances the p62âNRF2 interaction (FigÂ <xref rid="embj201798358-fig-0003" ref-type="fig">3</xref>C). The p62 interacts with KEAP1, sequesters it, and mediates its autophagic degradation. TRIM16 was found to increase the interaction between KEAP1 and p62 in immunoprecipitation assays (FigÂ <xref rid="embj201798358-fig-0003" ref-type="fig">3</xref>D). In our model, TRIM16 stabilizes NRF2 by utilizing at least two mechanisms, one, by displacing KEAP1, and two, by increasing p62âNRF2 interaction (FigÂ <xref rid="embj201798358-fig-0003" ref-type="fig">3</xref>E). Further, TRIM16 enhances the KEAP1 interaction with p62 leading to the sequestration and autophagic degradation of KEAP1 (FigÂ <xref rid="embj201798358-fig-0003" ref-type="fig">3</xref>E).</p>
        <fig fig-type="Figure" xml:lang="en" id="embj201798358-fig-0003" orientation="portrait" position="float">
          <label>Figure 3</label>
          <caption>
            <title>
<styled-content style="fixed-case">TRIM</styled-content>16 perturbs the interactions of the p62â<styled-content style="fixed-case">KEAP</styled-content>1â<styled-content style="fixed-case">NRF</styled-content>2 complex</title>
            <p>
<list list-type="simple" id="embj201798358-list-0004"><list-item><label>A, B</label><p>CoâIP analysis of the interaction between NRF2 and KEAP1 in absence and presence of TRIM16.</p></list-item><list-item><label>C</label><p>CoâIP analysis of the interaction between NRF2 and p62 in absence and presence of TRIM16.</p></list-item><list-item><label>D</label><p>CoâIP analysis of the interaction between KEAP1 and p62 in absence and presence of TRIM16.</p></list-item><list-item><label>E</label><p>Graphical representation of data presented in FigsÂ <xref rid="embj201798358-fig-0002" ref-type="fig">2</xref> and <xref rid="embj201798358-fig-0003" ref-type="fig">3</xref>.</p></list-item></list>
</p>
            <p>
<named-content content-type="attribution">Source data are available online for this figure.</named-content>
</p>
          </caption>
          <graphic id="nlm-graphic-13" xlink:href="EMBJ-37-e98358-g006"/>
        </fig>
        <p>Taken together, the data shown here suggest that TRIM16 is an integral part of the p62âKEAP1âNRF2 system and positively regulates expression of p62 and NRF2.</p>
      </sec>
      <sec id="embj201798358-sec-0005">
        <title>TRIM16 affects ubiquitination status of NRF2 and modulates itsÂ activity</title>
        <p>TRIM16 belongs to TRIM family proteins whose most of the members are RING domain containing E3 ligases (Hatakeyama, <xref rid="embj201798358-bib-0026" ref-type="ref">2017</xref>). TRIM16 is devoid of RING domain; however, it still holds E3 ligase activity (Bell <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0004" ref-type="ref">2012</xref>). So next we tested whether TRIM16 affects ubiquitination status of NRF2. The K48âlinked polyâubiquitination of a protein is known to target it for proteasomal degradation and the K63âlinked polyâubiquitination is important for varied functions including protein trafficking, proteins oligomerization, protein stability, and activation of signaling pathways (Jiang <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0032" ref-type="ref">2012</xref>; Nazio <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0066" ref-type="ref">2013</xref>; Erpapazoglou <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0020" ref-type="ref">2014</xref>; Choi <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0013" ref-type="ref">2016</xref>). To determine how TRIM16 affects NRF2 ubiquitination, we performed immunoprecipitation assays in the presence of two different variants of ubiquitin proteins, one that can only be ubiquitinated at lysine 48 residue (HAâK48âUB) and other that can only be ubiquitinated at lysine 63 residue (HAâK63âUB). Interestingly, we found that TRIM16 decreased K48âlinked polyâubiquitination and increased K63âlinked polyâubiquitination of NRF2 (FigÂ <xref rid="embj201798358-fig-0004" ref-type="fig">4</xref>AâC). In similar experiments, no change in NRF2 ubiquitination was observed in the presence of GFP control vector (<xref rid="embj201798358-sup-0001" ref-type="supplementary-material">AppendixÂ Fig S3A and B</xref>). To further corroborate the finding, we replaced HAâUbâK63 with histidineâtagged ubiquitinâK63 (all lysine mutated except K63) and performed NiâNTA pullâdown assays in denaturing (6M guanidineâHCl) and nonâdenaturing conditions. The data show that TRIM16 increases conjugation of ubiquitins with NRF2 (FigÂ <xref rid="embj201798358-fig-0004" ref-type="fig">4</xref>D and E). The decrease in K48âlinked ubiquitination of NRF2 could be due to the TRIM16âmediated displacement and degradation of KEAP1 which along with Cullin3 is known to cause K48âlinked ubiquitination and degradation of NRF2 (Kansanen <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0036" ref-type="ref">2013</xref>). Several of the proteins get stabilized upon K63âlinked ubiquitination (Nazio <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0066" ref-type="ref">2013</xref>; Choi <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0013" ref-type="ref">2016</xref>). Thus, both of these events can provide reasons for enhanced stability of NRF2 in the presence of TRIM16.</p>
        <fig fig-type="Figure" xml:lang="en" id="embj201798358-fig-0004" orientation="portrait" position="float">
          <label>Figure 4</label>
          <caption>
            <title>
<styled-content style="fixed-case">TRIM</styled-content>16 regulates ubiquitination of <styled-content style="fixed-case">NRF</styled-content>2</title>
            <p>
<list list-type="simple" id="embj201798358-list-0005"><list-item><label>AâC</label><p>Analysis of NRF2 ubiquitination in absence and presence of TRIM16 by coâIP assays using transiently transfected plasmid constructs as indicated. Two different variants of ubiquitin protein are used, one that can only be ubiquitinated at lysine 48 residue (HAâK48âUB) and other that can be only ubiquitinated at lysine 63 residue (HAâK63âUB). All other lysine residues are mutated. L.E, low exposure; H.E, high exposure.</p></list-item><list-item><label>D, E</label><p>Analysis of NRF2 ubiquitination in absence and presence of TRIM16 by NiâNTA pullâdown assays using transiently transfected plasmid constructs as indicated. Hisâtagged ubiquitin which is mutated at all lysines except 63 position is used in these assays.</p></list-item><list-item><label>F</label><p>Analysis of NRF2 ubiquitination in absence and presence of TRIM16 deletion variants by coâIP assays using transiently transfected plasmid constructs as indicated.</p></list-item><list-item><label>G</label><p>Western blot analysis of lysates from HeLa, TRIM16<sup>KO</sup> cells, and TRIM16<sup>KO</sup> cells complemented with TRIM16 deletion constructs where cells were treated with MG132 (20Â Î¼M, 2Â h) and the blot is probed with indicated antibodies.</p></list-item><list-item><label>H</label><p>Western blot analysis of lysates from HeLa, TRIM16<sup>KO</sup> cells, and TRIM16<sup>KO</sup> cells complemented with TRIM16 deletion constructs where cells were treated with MG132 (20Â Î¼M, 2Â h) and the blot is probed with indicated antibodies.</p></list-item></list>
</p>
            <p>
<named-content content-type="attribution">Source data are available online for this figure.</named-content>
</p>
          </caption>
          <graphic id="nlm-graphic-15" xlink:href="EMBJ-37-e98358-g008"/>
        </fig>
        <p>Next, we examined that which domain/s of TRIM16 is/are involved in K63âlinked ubiquitination of NRF2 (FigÂ <xref rid="embj201798358-fig-0004" ref-type="fig">4</xref>F). The data show that B1/B2 domains which were previously shown to be important for E3 ligase activity of TRIM16 (Bell <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0004" ref-type="ref">2012</xref>) play an important role in K63âlinked ubiquitination of NRF2 as their deletion substantially reduced the K63âlinked ubiquitination of NRF2 (FigÂ <xref rid="embj201798358-fig-0004" ref-type="fig">4</xref>F). The SPRY domain also appears to play a role in K63âlinked ubiquitination of NRF2, as the ubiquitination was low in the absence of the SPRY domain and also SPRY domain itself is sufficient to increase K63âlinked ubiquitination of NRF2 (FigÂ <xref rid="embj201798358-fig-0004" ref-type="fig">4</xref>F). It appears that either SPRY domain itself can ubiquitinate NRF2 or it interacts withÂ some other E3 ligase/s to achieve this. The latter is more likely,Â as the TRIM proteins are known for their tendency to heterodimerize with other TRIM proteins (Bell <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0004" ref-type="ref">2012</xref>; Marin, <xref rid="embj201798358-bib-0062" ref-type="ref">2012</xref>; Hatakeyama, <xref rid="embj201798358-bib-0026" ref-type="ref">2017</xref>).</p>
        <p>We found that the SPRY domain of TRIM16 is required for its interaction with p62 and NRF2 (FigÂ <xref rid="embj201798358-fig-0002" ref-type="fig">2</xref>L and O). Further, along with B1/B2 boxes, SPRY domain increases K63âlinked ubiquitination of NRF2 (FigÂ <xref rid="embj201798358-fig-0004" ref-type="fig">4</xref>F). We next complemented the TRIM16<sup>KO</sup> cells with TRIM16 deletion constructs to understand the role of TRIM16 domains in the stability of NRF2 and p62 under proteotoxic stress conditions (FigÂ <xref rid="embj201798358-fig-0004" ref-type="fig">4</xref>G). The fullâlength TRIM16 is able to completely restore the NRF2 and p62 levels in TRIM16<sup>KO</sup> cells, again showing the role of TRIM16 in maintaining the stability of NRF2 and p62. Notably, the SPRY domain alone can completely restore NRF2/p62 levels (FigÂ <xref rid="embj201798358-fig-0004" ref-type="fig">4</xref>G). Also, the SPRY domain deletion construct was defective in replenishing the NRF2/p62 expression suggesting that SPRY domain is required for full expression of NRF2/p62. The B1/B2 boxes mutant also appear to be slightly defective in the restoration of NRF2/p62 levels. Taken together, the data indicate that the SPRY domain of TRIM16 by its ability to mediate TRIM16 interaction and K63âlinked ubiquitination of NRF2 plays a critical role in NRF2/p62 stability and expression.</p>
        <p>To understand the functional significance of the results obtained above, we complemented the TRIM16<sup>KO</sup> cells with fullâlength or TRIM16 deletion constructs and assayed for protein aggregate formation under proteotoxic stress conditions (FigÂ <xref rid="embj201798358-fig-0003ev" ref-type="fig">EV3</xref>A and B). The results show that fullâlength mycâTRIM16 construct nicely restored the defective aggregate formation capacity of TRIM16<sup>KO</sup> cells (FigÂ <xref rid="embj201798358-fig-0003ev" ref-type="fig">EV3</xref>A and B). However, TRIM16 constructs deleted of B1/B2 or SPRY domains cannot (FigÂ <xref rid="embj201798358-fig-0003ev" ref-type="fig">EV3</xref>A and B). Interestingly, the TRIM16 SPRY domain can complement the protein aggregate formation capacity of TRIM16<sup>KO</sup> cells, whereas CCD domain cannot. Similar results were obtained in the Western blotting experimentÂ with the polyâubiquitin antibody (FigÂ <xref rid="embj201798358-fig-0004" ref-type="fig">4</xref>H). These data are in agreement with the important role of TRIM16 SPRY and B1/B2 domains in interaction, ubiquitination, and stability of p62 and NRF2. Both of the proteins are absolutely required for protein aggregate formation.</p>
        <fig fig-type="Figure" xml:lang="en" specific-use="collapsible" id="embj201798358-fig-0003ev" orientation="portrait" position="float">
          <label>Figure EV3</label>
          <caption>
            <title>
<styled-content style="fixed-case">TRIM</styled-content>16 regulates ubiquitination of <styled-content style="fixed-case">NRF</styled-content>2 and governs the <styled-content style="fixed-case">NRF</styled-content>2 stress responses</title>
            <p>
<list list-type="simple" id="embj201798358-list-0013"><list-item><label>A</label><p>Representative confocal images of HeLa, TRIM16<sup>KO</sup> cells, and TRIM16<sup>KO</sup> cells complemented with TRIM16 deletion constructs where cells were treated with MG132 (20Â Î¼M, 2Â h) and the samples were processed for IF analysis with Ub antibody.</p></list-item><list-item><label>B</label><p>The graph shows the percentage of cells with Ubâpositive protein aggregates. Data from â¥Â 10 fields (40Ã), <italic>n</italic>Â =Â 3, meanÂ Â±Â SD, *<italic>P</italic>Â &lt;Â 0.005 (Student's unpaired <italic>t</italic>âtest).</p></list-item><list-item><label>C</label><p>HeLa and TRIM16<sup>KO</sup> cells were treated with MG132 (10Â Î¼M, 4Â h), and lysates were subjected to Western blotting with indicated antibodies.</p></list-item><list-item><label>D</label><p>WB analysis of HeLa and TRIM16<sup>KO</sup> lysates of cells treated with MG132 (10Â Î¼M, 4Â h) or/and BafA1 (300Â nM, 4Â h) as indicated and probed with antibodies as shown.</p></list-item><list-item><label>E</label><p>HeLa and TRIM16<sup>KO</sup> cells were treated with MG132 (10Â Î¼M, 4Â h), and lysates were subjected to Western blotting with indicated antibodies.</p></list-item><list-item><label>F</label><p>Quantification of UB lane intensity relative to actin. MeanÂ Â±Â SD, <italic>n</italic>Â =Â 3, *<italic>P</italic>Â &lt;Â 0.05.</p></list-item><list-item><label>G</label><p>HeLa and TRIM16<sup>KO</sup> cells were treated with MG132 (10Â Î¼M, 4Â h), and lysates were subjected to Western blotting with K48 and K63 and other indicated antibodies.</p></list-item><list-item><label>HâJ</label><p>RNA isolated from HeLa and TRIM16<sup>KO</sup> cells, untreated or treated with MG132 (20Â Î¼M, 2Â h), were subjected to qRTâPCR with primers of genes as indicated. The fold induction in MG132âtreated samples is calculated relative to untreated samples. MeanÂ Â±Â SD, <italic>n</italic>Â =Â 3, *<italic>P</italic>Â &lt;Â 0.05, #Insignificant.</p></list-item></list>Data information: Unless otherwise stated, scale bar: 10Â Î¼m.<named-content content-type="attribution">Source data are available online for this figure.</named-content>
</p>
          </caption>
          <graphic id="nlm-graphic-17" xlink:href="EMBJ-37-e98358-g007"/>
        </fig>
      </sec>
      <sec id="embj201798358-sec-0006">
        <title>TRIM16 controls NRF2 stress response and ubiquitination pathway gene expression</title>
        <p>NRF2 is a master transcription regulator of the antioxidant and antiâproteotoxic stress response (Takaya <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0089" ref-type="ref">2012</xref>; Jaramillo &amp; Zhang, <xref rid="embj201798358-bib-0031" ref-type="ref">2013</xref>; Kansanen <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0036" ref-type="ref">2013</xref>). Next, we investigated the TRIM16âmediated regulation of NRF2 under stress conditions. Oxidative stress (H<sub>2</sub>O<sub>2</sub> treatment) induces concentrationâ and timeâdependent expression of NRF2, p62, and TRIM16 in control cells (FigÂ <xref rid="embj201798358-fig-0005" ref-type="fig">5</xref>A, <xref rid="embj201798358-sup-0001" ref-type="supplementary-material">AppendixÂ Fig S3C</xref>). However, under similar conditions, a rapid reduction in NRF2 and p62 was observed in TRIM16âdepleted cells (FigÂ <xref rid="embj201798358-fig-0005" ref-type="fig">5</xref>A, <xref rid="embj201798358-sup-0001" ref-type="supplementary-material">AppendixÂ Fig S3C</xref>) suggesting that oxidative stressâinduced expression or the stability of NRF2 and p62 is dependent on TRIM16. This notion is further supported by an elegant experiment where we chased expression of NRF2, p62, and TRIM16 at higher concentration of H<sub>2</sub>O<sub>2</sub> (400Â Î¼M) for different time points (FigÂ <xref rid="embj201798358-fig-0005" ref-type="fig">5</xref>B). In control cells, the expression of NRF2, p62, and TRIM16 was increased in 30Â min and after that it rapidly decreased till 2 h time point (FigÂ <xref rid="embj201798358-fig-0005" ref-type="fig">5</xref>B and C). After this time point, we again pulsed the cells with H<sub>2</sub>O<sub>2</sub> (400Â Î¼M, red arrow in the FigÂ <xref rid="embj201798358-fig-0005" ref-type="fig">5</xref>B and C), which again increased the expression of all the three proteins and thereafter protein levels rapidly dropped at the 6 h time point (FigÂ <xref rid="embj201798358-fig-0005" ref-type="fig">5</xref>B and C). Of note, in TRIM16âdepleted cells, this cyclic expression was not observed and the NRF2 and p62 levels were constantly and rapidly reduced (FigÂ <xref rid="embj201798358-fig-0005" ref-type="fig">5</xref>B and C). These data suggest that under oxidative stress conditions, the expressions of TRIM16, NRF2, and p62 are coâregulated and TRIM16 is essential for increased expression and stability of NRF2 and p62. The MG132 treatment induces TRIM16âdependent expression of NRF2 (FigÂ <xref rid="embj201798358-fig-0003ev" ref-type="fig">EV3</xref>C and D); however, p62 protein expression (but not mRNA, see below) was reduced in the presence of MG132 (FigÂ <xref rid="embj201798358-fig-0003ev" ref-type="fig">EV3</xref>D). The latter could be due to autophagy inducing property of MG132 which is known to degrade p62 (FigÂ <xref rid="embj201798358-fig-0003ev" ref-type="fig">EV3</xref>D, bafilomycin A1 lanes; Lan <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0053" ref-type="ref">2015</xref>; Bao <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0003" ref-type="ref">2016</xref>). As<sub>2</sub>O<sub>3</sub>, another potent oxidative stress inducer, increases the expression of NRF2 and p62, and ubiquitin conjugation of proteins (FigÂ <xref rid="embj201798358-fig-0005" ref-type="fig">5</xref>D). This effect was abolished in the absence of TRIM16 (FigÂ <xref rid="embj201798358-fig-0005" ref-type="fig">5</xref>D). Overall, the results suggest a pivotal role of TRIM16 in oxidative/proteotoxic stressâinduced expression of NRF2 and p62.</p>
        <fig fig-type="Figure" xml:lang="en" id="embj201798358-fig-0005" orientation="portrait" position="float">
          <label>Figure 5</label>
          <caption>
            <title>
<styled-content style="fixed-case">TRIM</styled-content>16 regulates stressâinduced <styled-content style="fixed-case">NRF</styled-content>2 response including ubiquitination of protein aggregates</title>
            <p>
<list list-type="simple" id="embj201798358-list-0006"><list-item><label>A</label><p>Western blot analysis of HeLa and TRIM16<sup>KO</sup> lysates of cells treated with increasing concentrations of H<sub>2</sub>O<sub>2</sub> as specified and probed with antibodies as indicated.</p></list-item><list-item><label>B</label><p>WB analysis of HeLa and TRIM16<sup>KO</sup> lysates of cells treated with 400Â Î¼M of H<sub>2</sub>O<sub>2</sub> for different durations as indicated and probed with antibodies as shown. The red arrows indicate the time point where the cells were retreated with 400Â Î¼M of H<sub>2</sub>O<sub>2</sub>. L.E, low exposure; H.E, high exposure.</p></list-item><list-item><label>C</label><p>Densitometric analysis of NRF2 band intensity (in panel B) normalized with actin.</p></list-item><list-item><label>D</label><p>WB analysis of HeLa and TRIM16<sup>KO</sup> lysates of cells treated with 2.5Â Î¼M (2Â h) of As<sub>2</sub>O<sub>3</sub>.</p></list-item><list-item><label>EâG</label><p>RNA isolated from HeLa and TRIM16<sup>KO</sup> cells, untreated or treated with MG132 (20Â Î¼M, 2Â h), were subjected to qRTâPCR with primers of genes as indicated. The fold induction in MG132âtreated samples is calculated relative to untreated samples. MeanÂ Â±Â SD, <italic>n</italic>Â =Â 3, *<italic>P</italic>Â &lt;Â 0.05, **<italic>P</italic>Â &lt;Â 0.005 (Student's unpaired <italic>t</italic>âtest).</p></list-item><list-item><label>HâJ</label><p>RNA isolated from control and NRF2 knockdown HeLa cells transfected with control vector or MycâTRIM16 subjected to qRTâPCR with primers of genes as indicated. MeanÂ Â±Â SD, <italic>n</italic>Â =Â 3, **<italic>P</italic>Â &lt;Â 0.005, ***<italic>P</italic>Â &lt;Â 0.0005 (Student's unpaired <italic>t</italic>âtest).</p></list-item><list-item><label>K</label><p>Western blot analysis of HeLa and TRIM16<sup>KO</sup> lysates of cells treated with h increasing concentrations of H<sub>2</sub>O<sub>2</sub> as specified and probed with antibodies as indicated.</p></list-item><list-item><label>L</label><p>Densitometric analysis of Ub smear intensity normalized with actin. MeanÂ Â±Â SD, <italic>n</italic>Â =Â 3, *<italic>P</italic>Â &lt;Â 0.05 (Student's unpaired <italic>t</italic>âtest).</p></list-item><list-item><label>M</label><p>Representative confocal images of control, <italic>Ubb,</italic> and <italic>Ube2n</italic> siRNA transfected cells treated with H<sub>2</sub>O<sub>2</sub> (200Â Î¼M, 2Â h) and IF analysis was performed with Ub and p62 antibodies. Scale bar: 10Â Î¼m.</p></list-item><list-item><label>N</label><p>The graph shows the percentage of cells with protein aggregates. Data from â¥Â 10 microscopic fields for each condition (40Ã), <italic>n</italic>Â =Â 2, meanÂ Â±Â SD.</p></list-item><list-item><label>O</label><p>Western blot analysis of <italic>Ubb</italic> and <italic>Ube2n</italic> siRNA transfected cell lysates with antibodies as indicated.</p></list-item><list-item><label>P</label><p>Pictorial representation of results obtained in FigsÂ <xref rid="embj201798358-fig-0001" ref-type="fig">1</xref>, <xref rid="embj201798358-fig-0002" ref-type="fig">2</xref>, <xref rid="embj201798358-fig-0003" ref-type="fig">3</xref>, <xref rid="embj201798358-fig-0004" ref-type="fig">4</xref>, <xref rid="embj201798358-fig-0005" ref-type="fig">5</xref>.</p></list-item></list>
</p>
            <p>
<named-content content-type="attribution">Source data are available online for this figure.</named-content>
</p>
          </caption>
          <graphic id="nlm-graphic-19" xlink:href="EMBJ-37-e98358-g010"/>
        </fig>
        <p>The induction of heme oxygenaseâ1 (HOâ1), NAD(P)H dehydrogenase (quinone) 1 (NQO1), and p62 is a hallmark of the NRF2âmediated stress response (Loboda <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0057" ref-type="ref">2016</xref>). The MG132 induced mRNA expression of <italic>p62</italic>,<italic> Nqo1,</italic> and <italic>Hmox1</italic> (<xref rid="embj201798358-sup-0001" ref-type="supplementary-material">AppendixÂ Fig S3D</xref>) was significantly reduced in TRIM16âdepleted cells (FigÂ <xref rid="embj201798358-fig-0005" ref-type="fig">5</xref>EâG). Further, just overexpression of TRIM16 increased the mRNA levels of <italic>p62</italic>,<italic> Nqo1,</italic> and <italic>Hmox1</italic> and this increased expression were blunted on knocking down NRF2 (FigÂ <xref rid="embj201798358-fig-0005" ref-type="fig">5</xref>HâJ). Taken together, the data suggest that TRIM16 is required for NRF2âmediated stress response.</p>
        <p>Proteasomal dysfunction and oxidative stress induce imbalance in protein homeostasis and lead to increased Ubâtagged misfolded proteins which subsequently form protein aggregates. H<sub>2</sub>O<sub>2</sub> and MG132 treatments induce polyâubiquitination of misfolded proteins in control cells (FigsÂ <xref rid="embj201798358-fig-0005" ref-type="fig">5</xref>K and <xref rid="embj201798358-fig-0003ev" ref-type="fig">EV3</xref>E and F). In contrast, there was marked reduction in polyâubiquitination of proteins in TRIM16<sup>KO</sup> cells (FigsÂ <xref rid="embj201798358-fig-0005" ref-type="fig">5</xref>K and <xref rid="embj201798358-fig-0003ev" ref-type="fig">EV3</xref>E and F) indicating that TRIM16 is important for polyâubiquitination of misfolded proteins formed during oxidative or proteotoxic stress conditions. Both K48âlinked and K63âlinked ubiquitination of proteins were reduced in the absence of TRIM16 (FigÂ <xref rid="embj201798358-fig-0003ev" ref-type="fig">EV3</xref>G). We hypothesize that TRIM16 via NRF2 upregulates expression of genes required for ubiquitination of misfolded proteins. In mammals, the <italic>Ubb</italic> (ubiquitin B) and <italic>Ubc</italic> (ubiquitin C) genes encode for polyâubiquitin precursor proteins and are essential for polyâubiquitination of misfolded proteins (Pankiv <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0072" ref-type="ref">2007</xref>; Lim <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0056" ref-type="ref">2015</xref>; Pajares <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0071" ref-type="ref">2017</xref>). Transcription of both the <italic>Ubb</italic> and <italic>Ubc</italic> genes was increased upon treatment of cells with MG132 (<xref rid="embj201798358-sup-0001" ref-type="supplementary-material">AppendixÂ Fig S3D</xref>). The MG132âinduced <italic>Ubb</italic> but not <italic>Ubc</italic> transcription was significantly attenuated in TRIM16<sup>KO</sup> cells (FigsÂ <xref rid="embj201798358-fig-0005" ref-type="fig">5</xref>L and <xref rid="embj201798358-fig-0003ev" ref-type="fig">EV3</xref>H). Next, we examined the expression of several other sentinel ubiquitin pathway genes, including <italic>Ubaâ1</italic> (ubiquitinâactivating enzyme, E1), <italic>Ubaâ3</italic> (ubiquitinâactivating enzyme, E1), <italic>Ube2h</italic> (ubiquitinâconjugating enzyme, E2), <italic>Ube2n</italic> (ubiquitinâconjugating enzyme, E2), <italic>Ube2z</italic> (ubiquitinâconjugating enzyme, E2), <italic>Ubr2</italic> (ubiquitinâprotein ligase, E3), <italic>Cullin4B</italic> (ubiquitinâprotein ligase, E3), and <italic>Nedd8</italic> (a ubiquitinâlike protein). The expression of E1 enzymes, <italic>Ubaâ1</italic> but not <italic>Ubaâ3,</italic> was induced by MG132, and this increase was significantly attenuated in TRIM16<sup>KO</sup> cells (FigÂ <xref rid="embj201798358-fig-0003ev" ref-type="fig">EV3</xref>I). The transcription of all the three E2 enzymes (<italic>UBe2h, Ube2n,</italic> and <italic>Ube2z</italic>) tested was upregulated by MG132 and was reduced in TRIM16<sup>KO</sup> cells (FigÂ <xref rid="embj201798358-fig-0003ev" ref-type="fig">EV3</xref>J). The <italic>Ubr2</italic> and <italic>Cullin4b</italic> transcriptions were increased, but Nedd8 transcription was unaffected by MG132 (<xref rid="embj201798358-sup-0001" ref-type="supplementary-material">AppendixÂ Fig S3E</xref>). <italic>Ubr2</italic> and <italic>Cullin4b</italic> expressions were unaffected in TRIM16<sup>KO</sup> cells (<xref rid="embj201798358-sup-0001" ref-type="supplementary-material">AppendixÂ Fig S3F</xref>). To confirm the role of these ubiquitin genes in protein aggregate biogenesis, we knocked down two of the TRIM16âregulated ubiquitin pathway genes, <italic>Ubb,</italic> and <italic>Ube2n</italic> and measured the accumulation of protein aggregates under oxidative stress conditions. Very clearly, both of the genes are required for protein aggregate formation (FigÂ <xref rid="embj201798358-fig-0005" ref-type="fig">5</xref>M and N). In very few of the <italic>Ubb</italic> and <italic>Ube2n</italic> knockdown cells, we observed the formation of very small protein aggregates (B panels, FigÂ <xref rid="embj201798358-fig-0005" ref-type="fig">5</xref>M) suggesting that both of the gene products are required for proper and full assembly of protein aggregates. One of the reasons for reduced protein aggregates could be the reduced expression of p62 upon depletion of <italic>Ubb</italic> and <italic>Ube2n</italic> (FigÂ <xref rid="embj201798358-fig-0005" ref-type="fig">5</xref>O). These data show that TRIM16 is important for proteotoxic/oxidative stressâinduced transcription of several sentinel genes of ubiquitin system (<italic>Ubb, Ubaâ1, Ube2h, Ube2n,</italic> and <italic>Ube2z</italic>) and is required for ubiquitination of misfolded proteins leading to the formation of protein aggregates.</p>
        <p>Taken together, we show that under stress conditions, TRIM16 coâregulates with NRF2 and p62 and is required for stressâinduced expression and stability of NRF2 and p62 (FigÂ <xref rid="embj201798358-fig-0005" ref-type="fig">5</xref>P). The TRIM16 via stabilized NRF2 induces p62, ubiquitin system pathway genes, and antioxidant genes for stress response which includes biogenesis of protein aggregates (FigÂ <xref rid="embj201798358-fig-0005" ref-type="fig">5</xref>P).</p>
      </sec>
      <sec id="embj201798358-sec-0007">
        <title>In a feedback loop, NRF2 regulates TRIM16 expression</title>
        <p>Previous studies indicate, however, without any direct evidence that TRIM16 is an NRF2âregulated stressâinduced gene (Noguchi, <xref rid="embj201798358-bib-0069" ref-type="ref">2008</xref>; Python <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0074" ref-type="ref">2009</xref>; Hirose <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0027" ref-type="ref">2011</xref>; Dodson <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0018" ref-type="ref">2015</xref>; Lacher &amp; Slattery, <xref rid="embj201798358-bib-0051" ref-type="ref">2016</xref>; Pajares <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0071" ref-type="ref">2017</xref>). We show that NRF2 silencing by siRNA results in decreased TRIM16 expression both at the protein and at the mRNA level (FigsÂ <xref rid="embj201798358-fig-0006" ref-type="fig">6</xref>A and <xref rid="embj201798358-fig-0004ev" ref-type="fig">EV4</xref>A and B). The p62 which is a known NRF2âtargeted gene also showed reduced expression (FigsÂ <xref rid="embj201798358-fig-0006" ref-type="fig">6</xref>A and <xref rid="embj201798358-fig-0004ev" ref-type="fig">EV4</xref>A and B). So NRF2 positively regulates both TRIM16 and p62 expression, and both TRIM16 and p62 are the positive regulators of NRF2 resulting in a regulatory feedback loop.</p>
        <fig fig-type="Figure" xml:lang="en" id="embj201798358-fig-0006" orientation="portrait" position="float">
          <label>Figure 6</label>
          <caption>
            <title>
<styled-content style="fixed-case">NRF</styled-content>2 regulates <styled-content style="fixed-case">TRIM</styled-content>16, ubiquitin pathway genes expression, and biogenesis of protein aggregates</title>
            <p>
<list list-type="simple" id="embj201798358-list-0007"><list-item><label>A</label><p>Control or NRF2 siRNA transfected HeLa cells lysates were subjected to Western blotting with indicated antibodies.</p></list-item><list-item><label>B, C</label><p>RNA isolated from untreated or MG132âtreated (20Â Î¼M, 2Â h) control or NRF2 siRNA transfected cells was subjected to qRTâPCR with primers of genes as indicated. The fold induction in MG132âtreated samples is calculated relative to untreated samples. MeanÂ Â±Â SD, <italic>n</italic>Â =Â 3, *<italic>P</italic>Â &lt;Â 0.05 (Student's unpaired <italic>t</italic>âtest).</p></list-item><list-item><label>D, E</label><p>WB analysis of control siRNA or NRF2 siRNA transfected lysates of HeLa cells, untreated or treated with MG132 (20Â Î¼M, 2Â h) or H<sub>2</sub>O<sub>2</sub> (200Â Î¼M, 2Â h) as indicated and probed with antibodies as shown. L.E, low exposure; H.E, High Exposure.</p></list-item><list-item><label>F, G</label><p>Left panels: Representative confocal images of control siRNA and NRF2 siRNA transfected cells treated with (F) MG132 (20Â Î¼M, 2Â h), (G) H<sub>2</sub>O<sub>2</sub> (200Â Î¼M, 2Â h), where IF analysis was conducted with Ub and p62 antibodies. Right panels: Fluorescence intensity line is tracing corresponding to a white line in zoom panel.</p></list-item><list-item><label>H</label><p>HeLa cells, TRIM16<sup>KO</sup> cells, and TRIM16<sup>KO</sup> cells complemented with MycâNRF2 or GFPâNRF2 were treated with MG132 (20Â Î¼M, 2Â h) and subjected to WB analysis with Myc, GFP, and indicated antibodies.</p></list-item><list-item><label>I</label><p>Representative confocal images of HeLa cells, TRIM16<sup>KO</sup> cells, and TRIM16<sup>KO</sup> cells complemented with MycâNRF2 which were treated with MG132 (20Â Î¼M, 2Â h) and subjected to IF with Ub and p62 antibodies.</p></list-item><list-item><label>J</label><p>Graph represent % of cells with Ubâp62 dots, data from â¥Â 10 microscopic fields (40Ã), <italic>n</italic>Â =Â 3, meanÂ Â±Â SD, *<italic>P</italic>Â &lt;Â 0.005 (oneâway ANOVA test).</p></list-item><list-item><label>K</label><p>Graphical representation of results obtained.</p></list-item></list>Data information: Unless otherwise stated, scale bar: 10Â Î¼m.<named-content content-type="attribution">Source data are available online for this figure.</named-content>
</p>
          </caption>
          <graphic id="nlm-graphic-21" xlink:href="EMBJ-37-e98358-g012"/>
        </fig>
        <fig fig-type="Figure" xml:lang="en" specific-use="collapsible" id="embj201798358-fig-0004ev" orientation="portrait" position="float">
          <label>Figure EV4</label>
          <caption>
            <title>
<styled-content style="fixed-case">NRF</styled-content>2 regulates <styled-content style="fixed-case">TRIM</styled-content>16, ubiquitin pathway genes expression, and biogenesis of protein aggregates</title>
            <p>
<list list-type="alpha-upper" id="embj201798358-list-0014"><list-item><p>Control or NRF2 siRNA transfected HeLa cells lysates were subjected to Western blotting with indicated antibodies (different protein concentrations as indicated).</p></list-item><list-item><p>RNA isolated from untreated or MG132âtreated control (20Â Î¼M, 2Â h) or NRF2 siRNA transfected cells were subjected to qRTâPCR with primers of genes as indicated. The fold induction in MG132âtreated samples is calculated relative to untreated samples.</p></list-item><list-item><p>WB analysis of control siRNA or NRF2 siRNA transfected lysates of HeLa cells probed with antibodies as shown.</p></list-item><list-item><p>Left panels: Confocal images of control and NRF2 siRNA transfected cells treated with H<sub>2</sub>O<sub>2</sub> (200Â Î¼M, 2Â h) where IF analysis was conducted with Ub and LC3B antibodies. Right panels: Fluorescence intensity line is tracing corresponding to a white line in zoom panel. Arrowheads indicate the puncta where coâlocalization between UB and LC3B is observed.</p></list-item><list-item><p>Representative confocal images of control and NRF2 siRNA transfected cells treated with MG132 (20Â Î¼M, 2Â h) and bafilomycin A1 (300Â nM, 3Â h) and IF analysis was conducted with Ub and LC3B antibodies. Right panels: fluorescence intensity line is tracing corresponding to the white line (inset).</p></list-item><list-item><p>Representative confocal images of HeLa cells, TRIM16<sup>KO</sup> cells, and TRIM16<sup>KO</sup> cells complemented with MycâNRF2 were treated with MG132 (20Â Î¼M, 2Â h) and subjected to IF with Ub and p62 antibodies.</p></list-item></list>Data information: Unless otherwise stated, scale bar: 10Â Î¼m.<named-content content-type="attribution">Source data are available online for this figure.</named-content>
</p>
          </caption>
          <graphic id="nlm-graphic-23" xlink:href="EMBJ-37-e98358-g009"/>
        </fig>
      </sec>
      <sec id="embj201798358-sec-0008">
        <title>NRF2 is a central player in stressâinduced TRIM16 protein aggregate biogenesis response</title>
        <p>Given the role of NRF2 in stressâinduced detoxification processes, we hypothesize that some of the TRIM16 functions revealed above are mediated through NRF2. Indeed, the aboveâmentioned ubiquitin system genes are regulated by NRF2 (FigsÂ <xref rid="embj201798358-fig-0006" ref-type="fig">6</xref>B and C, and <xref rid="embj201798358-fig-0004ev" ref-type="fig">EV4</xref>B) indicating that TRIM16 modulates the expression of these genes through NRF2âmediated transcriptional regulation. Further, like TRIM16, the knockdown of NRF2 reduced the MG132â and H<sub>2</sub>O<sub>2</sub>âinduced polyâubiquitination of misfolded proteins or protein aggregates (FigsÂ <xref rid="embj201798358-fig-0006" ref-type="fig">6</xref>D and E, and <xref rid="embj201798358-fig-0004ev" ref-type="fig">EV4</xref>C). Furthermore, we found that NRF2 depletion substantially reduced the Ub, p62, and LC3B marked protein aggregates formed during oxidative and proteotoxic stress conditions (FigsÂ <xref rid="embj201798358-fig-0006" ref-type="fig">6</xref>F and G, and <xref rid="embj201798358-fig-0004ev" ref-type="fig">EV4</xref>D and E). This phenotype of NRF2 depletion is noticeable and maybe because of the reduced expression of TRIM16, p62, and ubiquitin genes in these cells (FigÂ <xref rid="embj201798358-fig-0006" ref-type="fig">6</xref>A and B).</p>
        <p>Next, we examined, whether NRF2 complementation in TRIM16<sup>KO</sup> cells can compensate for the ubiquitination and protein aggregate formation defects observed in TRIM16âdepleted cells. We found that the NRF2 complemented TRIM16<sup>KO</sup> cells showed an increased ability of protein ubiquitination (FigÂ <xref rid="embj201798358-fig-0006" ref-type="fig">6</xref>H) and Ubâp62âpositive aggresome formation (FigsÂ <xref rid="embj201798358-fig-0006" ref-type="fig">6</xref>I and J, and <xref rid="embj201798358-fig-0004ev" ref-type="fig">EV4</xref>F). The observed increased accumulation of Ubâp62âpositive aggresomes in NRF2âcomplemented cells compared to wildâtype cells could be due to their incapability of autophagic degradation in the absence of TRIM16 which is important for degradation of protein aggregates (see below). Altogether, we show that the NRF2 plays a central role in the TRIM16âmediated stress response of formation of protein aggregates from misfolded proteins (FigÂ <xref rid="embj201798358-fig-0006" ref-type="fig">6</xref>K).</p>
      </sec>
      <sec id="embj201798358-sec-0009">
        <title>TRIM16 act as a scaffold protein and is important for autophagic clearance of protein aggregates</title>
        <p>TRIM16 is a positive regulator of autophagy (FigsÂ <xref rid="embj201798358-fig-0001" ref-type="fig">1</xref>K and L, and <xref rid="embj201798358-fig-0001ev" ref-type="fig">EV1</xref>I and J). Next, we tested whether TRIM16 in addition to biogenesis has a role in the autophagic degradation of protein aggregates. Since TRIM16 is required for ubiquitination and protein aggregation, it is not possible to study the role of TRIM16 in degradation of endogenous protein aggregates in isolation. To investigate this, we studied the role of TRIM16 in degradation of protein aggregates formed by selfâoligomerization (such as p62) or aggregationâprone proteins (such as expanded huntingtin exon 1 Q74). Recent studies suggest that the ubiquitination process is not essential for the formation of aggregates of such proteins (Gal <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0023" ref-type="ref">2009</xref>; Riley <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0076" ref-type="ref">2010</xref>; Bersuker <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0006" ref-type="ref">2016</xref>); however, it is important for their degradation via autophagy (Bjorkoy <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0008" ref-type="ref">2005</xref>; Pankiv <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0072" ref-type="ref">2007</xref>). Since selfâoligomerizing or aggregationâprone proteins form aggregates independent of ubiquitination, their aggregation may not be hindered in TRIM16âdepleted cells, and therefore, utilizing this system, we can study the role of TRIM16 in degradation of protein aggregates. We overexpressed p62 in control and TRIM16<sup>KO</sup> cells. Interestingly, we found that the p62 aggregates were accumulated more in TRIM16<sup>KO</sup> cells compared to the control cells in immunofluorescence and also in soluble/insoluble fractionation Western blotting experiments (FigsÂ <xref rid="embj201798358-fig-0007" ref-type="fig">7</xref>A and B, and <xref rid="embj201798358-fig-0005ev" ref-type="fig">EV5</xref>A and B) indicating the role of TRIM16 in degradation of p62 aggregates. The p62 aggregates are predominantly degraded by autophagy process (Bjorkoy <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0008" ref-type="ref">2005</xref>). A similar increased accumulation of GFPâHuntington exon 1 (Q74) aggregates, another wellâdocumented autophagy cargo (Ravikumar <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0075" ref-type="ref">2004</xref>; Komatsu <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0046" ref-type="ref">2007a</xref>), was observed in insoluble fraction of TRIM16<sup>KO</sup> cells compared to HeLa cells (FigÂ <xref rid="embj201798358-fig-0007" ref-type="fig">7</xref>C and D) underscoring the importance of TRIM16 in degradation of autophagic cargoes. Further, the p62 aggregates in TRIM16âdepleted cells displayed reduced ubiquitination (FigÂ <xref rid="embj201798358-fig-0005ev" ref-type="fig">EV5</xref>C and D, <xref rid="embj201798358-sup-0001" ref-type="supplementary-material">AppendixÂ Fig S3F</xref>) and reduced coâlocalization with LC3B (FigÂ <xref rid="embj201798358-fig-0005ev" ref-type="fig">EV5</xref>E and F). Taken together, these data indicate that TRIM16 is important for degradation of protein aggregates destined for autophagic degradation.</p>
        <fig fig-type="Figure" xml:lang="en" id="embj201798358-fig-0007" orientation="portrait" position="float">
          <label>Figure 7</label>
          <caption>
            <title>
<styled-content style="fixed-case">TRIM</styled-content>16 mediates selective clearance of aggregated autophagy cargoes</title>
            <p>
<list list-type="simple" id="embj201798358-list-0008"><list-item><label>AâD</label><p>(A, C) WB analysis of detergentâsoluble and âinsoluble fractions of HeLa and TRIM16<sup>KO</sup> cells expressing either (A) Flagâp62 or (C) GFPâpolyQ74 probed with Flag or GFP or indicated antibodies. L.E, low exposure; H.E, high exposure. (B, D) Densitometric analysis of WB's (shown in panels A and C) normalized with Î±âtubulin or laminâB1.</p></list-item><list-item><label>E</label><p>Confocal images of GFPâTRIM16âexpressing HeLa cells, untreated or treated with MG132 (10Â Î¼M, 4Â h) and/or bafilomycin A1 (300Â nM, 3Â h) and IF analysis is performed with antibodies as indicated. Right panel graphs: Fluorescence intensity line is tracing corresponding to a white line in zoom panel. Scale bar: 10Â Î¼m.</p></list-item><list-item><label>F</label><p>The graph shows the percentage of cells with TRIM16âUb or TRIM16âUbâp62 coâlocalized dots/aggregates. Data from â¥Â 10 microscopic fields, <italic>n</italic>Â =Â 2, meanÂ Â±Â SD.</p></list-item><list-item><label>G</label><p>Representative confocal images of GFPâTRIM16 expressing HeLa cells, untreated or treated with MG132 (10Â Î¼M, 4Â h) and/or bafilomycin A1 (300Â nM, 3Â h) and IF analysis is performed with antibodies as indicated. Right panel graphs: Fluorescence intensity line is tracing corresponding to a white line in zoom panel. Scale bar: 10Â Î¼m.</p></list-item><list-item><label>H</label><p>CoâIP analysis of the interaction between two differently tagged TRIM16 variants.</p></list-item><list-item><label>I</label><p>WB analysis of detergentâsoluble and detergentâinsoluble DSS crossâlinked fractions of HeLa and TRIM16<sup>KO</sup> cells, untreated or treated with MG132 (10Â Î¼M, 4Â h) and probed with indicated antibodies.</p></list-item><list-item><label>J</label><p>CoâIP analysis of the interaction between Flagâtagged TRIM16 and Mycâtagged TRIM16 full length and its domain deletion proteins.</p></list-item></list>
</p>
            <p>
<named-content content-type="attribution">Source data are available online for this figure.</named-content>
</p>
          </caption>
          <graphic id="nlm-graphic-25" xlink:href="EMBJ-37-e98358-g013"/>
        </fig>
        <fig fig-type="Figure" xml:lang="en" specific-use="collapsible" id="embj201798358-fig-0005ev" orientation="portrait" position="float">
          <label>Figure EV5</label>
          <caption>
            <title>
<styled-content style="fixed-case">TRIM</styled-content>16 mediates selective clearance of aggregated autophagy cargoes</title>
            <p>
<list list-type="simple" id="embj201798358-list-0015"><list-item><label>A</label><p>Representative confocal images of HeLa and TRIM16<sup>KO</sup> cells transiently expressing Flagâp62.</p></list-item><list-item><label>B</label><p>The graph shows the percentage of transfected cells with p62âaggregates. Data from â¥Â 10 microscopic fields for each condition (40Ã), <italic>n</italic>Â =Â 3, meanÂ Â±Â SD, *<italic>P</italic>Â &lt;Â 0.05 (Student's unpaired <italic>t</italic>âtest).</p></list-item><list-item><label>CâF</label><p>(C, E) Representative confocal images of HeLa and TRIM16<sup>KO</sup> cells expressing Flagâp62 and IF analysis was performed with Flag and (C) Ub or (E) LC3B antibodies. (D, F) The graph shows the percentage of cells with p62âUb (D) or p62âLC3B (F) coâlocalized aggregates. Data from â¥Â 10 microscopic fields, <italic>n</italic>Â =Â 3, meanÂ Â±Â SD, *<italic>P</italic>Â &lt;Â 0.05 (Student's unpaired <italic>t</italic>âtest).</p></list-item><list-item><label>G</label><p>WB analysis of detergentâsoluble and detergentâinsoluble fractions of HeLa and TRIM16<sup>KO</sup> cells, untreated or treated with MG132 (10Â Î¼M, 4Â h), and probed with indicated antibodies.</p></list-item><list-item><label>H</label><p>Representative confocal images of HEK293T cells transiently expressing GFPâTRIM16 and MycâTRIM16.</p></list-item><list-item><label>I</label><p>Upper panel, representative confocal images of control or p62 siRNA transfected HeLa cells transiently expressing GFPâTRIM16. Lower panel, WB showing the knockdown efficiency of p62 siRNA.</p></list-item><list-item><label>J</label><p>Representative confocal images of HeLa cells expressing GFPâTRIM16, FlagâULK1, or FlagâATG16L1 treated with MG132 (10Â Î¼M, 4Â h) and/or bafilomycin A1 (300Â nM, 3Â h) and IF analysis is performed with antibodies as indicated. Right: Fluorescence intensity line is tracing corresponding to the white line.</p></list-item><list-item><label>K</label><p>Representative confocal images of starved and unstarved HEK293T cells transiently expressing mcherryâYFPâTRIM16.</p></list-item></list>Data information: Unless otherwise stated, scale bar: 10Â Î¼m.<named-content content-type="attribution">Source data are available online for this figure.</named-content>
</p>
          </caption>
          <graphic id="nlm-graphic-27" xlink:href="EMBJ-37-e98358-g011"/>
        </fig>
        <p>To further substantiate this observation, we determined whether TRIM16 is physically present over the aggresomes and participates directly in their turnover. Under basal conditions, the GFPâTRIM16 mostly showed diffused cytoplasmic staining or occasional dots (aggregates) coâlocalizing with Ub but not with p62 (FigÂ <xref rid="embj201798358-fig-0007" ref-type="fig">7</xref>E and F). In MG132âtreated cells, GFPâTRIM16 strongly coâlocalizes with Ubâpositive aggresomes; however, the triple coâlocalization of TRIM16, Ub, and p62 was only observed in a few of the cells (FigÂ <xref rid="embj201798358-fig-0007" ref-type="fig">7</xref>E and F). Since MG132 induces autophagy flux which can lead to the autophagic degradation of p62 and protein aggregates (Lan <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0053" ref-type="ref">2015</xref>; Bao <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0003" ref-type="ref">2016</xref>), we performed immunofluorescence analysis in cells treated with MG132 and autophagy flux inhibitor, bafilomycin A1. This treatment substantially increased the coâlocalization between TRIM16, Ub, and p62 (FigÂ <xref rid="embj201798358-fig-0007" ref-type="fig">7</xref>E and F). A clear coâlocalization was also observed between TRIM16 and LC3B in the presence of MG132 or MG132 and bafilomycin A1 (FigÂ <xref rid="embj201798358-fig-0007" ref-type="fig">7</xref>G). Further, in immunoprecipitation assays, the affinity of TRIM16 for p62 and LC3B was increased upon treatment of the cell with MG132 (FigÂ <xref rid="embj201798358-fig-0002" ref-type="fig">2</xref>J, <xref rid="embj201798358-sup-0001" ref-type="supplementary-material">AppendixÂ Fig S3G</xref>). The data suggest that TRIM16 is present over the aggresome and coâlocalizes with p62 and LC3B. To corroborate these findings, Western blotting experiment with soluble/insoluble fractions was performed. The TRIM16 was specifically accumulated in the insoluble (aggresomes containing) fractions of MG132âtreated cells (FigÂ <xref rid="embj201798358-fig-0005ev" ref-type="fig">EV5</xref>G, compare lane 5 and 7). The presence of TRIM16 in protein aggregates and its requirement for the interaction of Ub, p62, and LC3B with the protein aggregates suggest that TRIM16 may act as a scaffold protein and assists in interactions. To assist in interactions, the scaffold proteins usually exist in oligomeric forms. Indeed, TRIM16 have tendency to selfâoligomerize (FigsÂ <xref rid="embj201798358-fig-0007" ref-type="fig">7</xref>H and <xref rid="embj201798358-fig-0005ev" ref-type="fig">EV5</xref>H) and is present as high molecular weight oligomers in the protein aggregate fraction, along with p62 (FigÂ <xref rid="embj201798358-fig-0007" ref-type="fig">7</xref>I). We further found that the CCD domain of TRIM16 was important for its oligomerization (FigÂ <xref rid="embj201798358-fig-0007" ref-type="fig">7</xref>J). It was interesting to note that the p62 is required for aggregation of TRIM16 (FigÂ <xref rid="embj201798358-fig-0005ev" ref-type="fig">EV5</xref>I).</p>
        <p>We have shown in a previous study that TRIM16 interacts with ULK1 and ATG16L1, the autophagy initiation, and elongation protein, on the damaged endomembranes (Chauhan <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0011" ref-type="ref">2016</xref>). We tested whether a similar association of TRIM16 and ULK1 or ATG16L1 takes place on the aggresomes. Under basal conditions, GFPâTRIM16 is localized diffusely in the cytoplasm, and a rare coâlocalization with either ULK1 or ATG16L1 was seen in HeLa cells, whereas in MG132âtreated cells, TRIM16 nicely coâlocalized with ULK1 and ATG16L1 on Ubâpositive aggresomes (FigÂ <xref rid="embj201798358-fig-0005ev" ref-type="fig">EV5</xref>J).</p>
        <p>Overall, we show that TRIM16 is physically present on the protein aggregates and associates with the ubiquitin and autophagy, adaptor (p62), initiation (ULK1), and elongation (ATG16L1, LC3B) proteins to promote the autophagic degradation of the protein aggregates.</p>
        <p>TRIM16 plays a role in the autophagic degradation of protein aggregates, but it appears that TRIM16 itself is not degraded by autophagy. On starving the cells, TRIM16 neither goes to lysosomal compartment as indicated by no change in color of dualâtagged TRIM16 (FigÂ <xref rid="embj201798358-fig-0005ev" ref-type="fig">EV5</xref>K) nor its protein levels were reduced (<xref rid="embj201798358-sup-0001" ref-type="supplementary-material">AppendixÂ Fig S3H</xref>).</p>
      </sec>
      <sec id="embj201798358-sec-0010">
        <title>TRIM16 protects cells from the toxic effects of oxidative and proteotoxic stresses</title>
        <p>TRIM16 is important to mount an antioxidant and antiâproteotoxic stress response. We next investigated the role of TRIM16 in the survival of cells subjected to these stresses. The basal growth rate of TRIM16<sup>KO</sup> cells was comparable to the control cells (FigÂ <xref rid="embj201798358-fig-0008" ref-type="fig">8</xref>A and B, <xref rid="embj201798358-sup-0001" ref-type="supplementary-material">AppendixÂ Fig S3I</xref>). However, under oxidative and proteotoxic stress conditions, TRIM16<sup>KO</sup> cells were significantly growth defective (FigÂ <xref rid="embj201798358-fig-0008" ref-type="fig">8</xref>A and B, <xref rid="embj201798358-sup-0001" ref-type="supplementary-material">AppendixÂ Fig S3J and K</xref>). We next employed the AnnexinâV/propidium iodide doubleâstaining to measure the apoptosis and cell death under basal and stressed conditions. As<sub>2</sub>O<sub>3</sub> and H<sub>2</sub>O<sub>2</sub> were used as oxidative stress inducers, and puromycin and MG132 were used to induce proteotoxic stress. Under basal conditions, no significant difference in apoptosis was observed between TRIM16<sup>KO</sup> and control cells (FigÂ <xref rid="embj201798358-fig-0008" ref-type="fig">8</xref>CâF). However, the TRIM16âdepleted cells showed increased apoptosis and cell death on exposure to AS<sub>2</sub>O<sub>3</sub>, H<sub>2</sub>O<sub>2</sub>, puromycin and MG132 (FigÂ <xref rid="embj201798358-fig-0008" ref-type="fig">8</xref>CâF). Further, increased cleavage of caspaseâ3 and PARPâ1, the apoptosis marker proteins were also observed in TRIM16âdepleted cells on exposure of As<sub>2</sub>O<sub>3</sub> or H<sub>2</sub>O<sub>2</sub> (FigÂ <xref rid="embj201798358-fig-0008" ref-type="fig">8</xref>G, <xref rid="embj201798358-sup-0001" ref-type="supplementary-material">AppendixÂ Fig S3K</xref>). Taken together, TRIM16 prevents oxidative/proteotoxic stressâinduced apoptosis/cell death.</p>
        <fig fig-type="Figure" xml:lang="en" id="embj201798358-fig-0008" orientation="portrait" position="float">
          <label>Figure 8</label>
          <caption>
            <title>
<styled-content style="fixed-case">TRIM</styled-content>16 reduces cytotoxicity mediated by oxidative and proteotoxic stresses</title>
            <p>
<list list-type="simple" id="embj201798358-list-0009"><list-item><label>A</label><p>MTT assays performed at different time points with HeLa and TRIM16<sup>KO</sup> cells, untreated or treated with H<sub>2</sub>O<sub>2</sub> (400Â Î¼M, 2Â h). Data, meanÂ Â±Â SD, <italic>n</italic>Â =Â 3, *<italic>P</italic>Â &lt;Â 0.05 (Student's unpaired <italic>t</italic>âtest).</p></list-item><list-item><label>B</label><p>Images of HeLa and TRIM16<sup>KO</sup> cells, untreated or treated with As<sub>2</sub>O<sub>3</sub> (2.5Â Î¼M, 4Â h). Scale bar: 400Â Î¼m.</p></list-item><list-item><label>CâF</label><p>Flow cytometry analysis of HeLa and TRIM16<sup>KO</sup> cells stained with AnnexinâV/propidium iodide (doubleâstaining), untreated or treated with (C) As<sub>2</sub>O<sub>3</sub> (2.5Â Î¼M, 4Â h), (D) H<sub>2</sub>O<sub>2</sub> (400Â Î¼M, 2Â h), (E) puromycin (5Â Î¼g/ml, 6Â h), and (F) MG132 (20Â Î¼M, 8Â h).</p></list-item><list-item><label>G</label><p>Immunoblot blot analysis of HeLa and TRIM16<sup>KO</sup> lysates of cells treated with 5Â Î¼M of As<sub>2</sub>O<sub>3</sub> for different durations as indicated and probed with antibodies as shown. L.E, low exposure; H.E, high exposure. Arrowheads indicate the cleaved form of PARPâ1 and caspaseâ3.</p></list-item></list>
</p>
            <p>
<named-content content-type="attribution">Source data are available online for this figure.</named-content>
</p>
          </caption>
          <graphic id="nlm-graphic-29" xlink:href="EMBJ-37-e98358-g014"/>
        </fig>
      </sec>
      <sec id="embj201798358-sec-0011">
        <title>TRIM16 prevents oxidative stressâinduced cytotoxicity <italic>In vivo</italic>
</title>
        <p>TRIM16âdepleted cells showed reduced colony formation capacity under oxidative or proteotoxic stress conditions in clonogenic assays (FigÂ <xref rid="embj201798358-fig-0009" ref-type="fig">9</xref>A and B). We employed xenograft BALB/Cânude mouse model to examine the role of TRIM16 in cell proliferation and growth <italic>inÂ vivo</italic>. An equal number of control and TRIM16<sup>KO</sup> cells were injected subcutaneously in lower flanks of mice. As<sub>2</sub>O<sub>3</sub> exposure is known to induce massive ROS production and DNA damage leading to cell death (Woo <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0094" ref-type="ref">2002</xref>; Selvaraj <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0084" ref-type="ref">2013</xref>). Once tumors are formed, a subâlethal dose of AS<sub>2</sub>O<sub>3</sub> (5Â mg/kg) was injected intraperitoneally in mice every alternate day until the termination of the experiment (FigÂ <xref rid="embj201798358-fig-0009" ref-type="fig">9</xref>C). In PBS (phosphate buffer saline)âtreated control group, no substantial difference in proliferation capacity of HeLa vs. TRIM16<sup>KO</sup> cells was observed (FigÂ <xref rid="embj201798358-fig-0009" ref-type="fig">9</xref>C and D). However, treatment of As<sub>2</sub>O<sub>3</sub> rapidly regressed the TRIM16<sup>KO</sup> tumors without affecting the growth of control tumors (FigÂ <xref rid="embj201798358-fig-0009" ref-type="fig">9</xref>C and D). No significant change in body weight of mice was observed during the course of the experiment (<xref rid="embj201798358-sup-0001" ref-type="supplementary-material">AppendixÂ Fig S4A</xref>). The mice were sacrificed, and tumor weight was measured, which was significantly lower in As<sub>2</sub>O<sub>3</sub>âtreated TRIM16<sup>KO</sup> group compared to other groups (FigÂ <xref rid="embj201798358-fig-0009" ref-type="fig">9</xref>E and F, <xref rid="embj201798358-sup-0001" ref-type="supplementary-material">AppendixÂ Fig S4B</xref>). Immunohistochemistry analysis (KIâ67 staining) revealed reduced proliferation in TRIM16<sup>KO</sup> tumors compared to control tumors (FigÂ <xref rid="embj201798358-fig-0009" ref-type="fig">9</xref>G). Western blot analysis of tumors lysates from two different mice emulated the key <italic>inÂ vitro</italic> findings of this study that TRIM16 is important for NRF2 and p62 expression and is required for stressâinduced polyâubiquitination of misfolded proteins (FigÂ <xref rid="embj201798358-fig-0009" ref-type="fig">9</xref>H). Altogether, we show in tumor model that TRIM16 modulates NRF2âp62 signaling and ubiquitin system to protect the cells against oxidative stressâinduced toxicity.</p>
        <fig fig-type="Figure" xml:lang="en" id="embj201798358-fig-0009" orientation="portrait" position="float">
          <label>Figure 9</label>
          <caption>
            <title>
<styled-content style="fixed-case">TRIM</styled-content>16 is protective against oxidative stressâinduced cytotoxicity <italic>inÂ vivo</italic>
</title>
            <p>
<list list-type="simple" id="embj201798358-list-0010"><list-item><label>A, B</label><p>Clonogenic assays were performed with HeLa and TRIM16<sup>KO</sup> cells, untreated or treated with As<sub>2</sub>O<sub>3</sub> or MG132.</p></list-item><list-item><label>C</label><p>Tumor volumes of HeLa and TRIM16<sup>KO</sup> tumors at indicated time points. As<sub>2</sub>O<sub>3</sub> is injected when tumor volume of all groups was &gt;Â 100Â mm<sup>3</sup> (day 0 in the graph). Tumor volumes were measured on an interval as indicated. MeanÂ Â±Â SE, <italic>n</italic>Â =Â 6 (each group), *<italic>P</italic>Â &lt;Â 0.05, **<italic>P</italic>Â &lt;Â 0.005, ***<italic>P</italic>Â &lt;Â 0.0005 (ANOVA).</p></list-item><list-item><label>D</label><p>Graph shows the % tumor regression (tumor volume on day 1 of As<sub>2</sub>O<sub>3</sub> treatment/tumor volume on day of sacrificeÂ ÃÂ 100). MeanÂ Â±Â SE, <italic>n</italic>Â =Â 6 (each group), **<italic>P</italic>Â &lt;Â 0.005 (Student's unpaired <italic>t</italic>âtest).</p></list-item><list-item><label>E</label><p>Representative images of HeLa and TRIM16<sup>KO</sup> tumors formed in the nude mice in the absence and presence of As<sub>2</sub>O<sub>3</sub>.</p></list-item><list-item><label>F</label><p>Representative pictures of dissected tumors.</p></list-item><list-item><label>G</label><p>Immunohistochemistry analysis performed with KIâ67 cell proliferation marker and hematoxylin nuclear stain. The graph represents the % of cells with KIâ67 staining. &gt;Â 400 cells were counted for this analysis from three different sections from different animals, meanÂ Â±Â SD, *<italic>P</italic>Â &lt;Â 0.05 (Student's unpaired <italic>t</italic>âtest). Scale bar: 50Â Î¼m.</p></list-item><list-item><label>H</label><p>WB analysis of tumor tissue lysates from two different mice with antibodies as indicated. L.E, low exposure; H.E, high exposure.</p></list-item><list-item><label>I</label><p>Graphical representation of work presented in this study.</p></list-item></list>
</p>
            <p>
<named-content content-type="attribution">Source data are available online for this figure.</named-content>
</p>
          </caption>
          <graphic id="nlm-graphic-31" xlink:href="EMBJ-37-e98358-g015"/>
        </fig>
      </sec>
    </sec>
    <sec id="embj201798358-sec-0012">
      <title>Discussion</title>
      <p>The occurrence of misfolded proteins and formation of misfolded protein aggregates is an unavoidable consequence of cellular protein biogenesis. The assembly of misfolded protein aggregates is a cytoprotective measure resulting in the sequestration of highly toxic free misfolded proteins or intermediate aggregates (Arrasate <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0002" ref-type="ref">2004</xref>; Tanaka <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0090" ref-type="ref">2004</xref>; Douglas <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0019" ref-type="ref">2008</xref>; Tyedmers <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0091" ref-type="ref">2010</xref>). The misfolded protein aggregates are rapidly cleared to maintain cellular homeostasis. The unresolved accumulation of protein aggregates is cytotoxic and implicated in the pathogenesis of several diseases (Hara <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0025" ref-type="ref">2006</xref>; Komatsu <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0047" ref-type="ref">2007b</xref>; Polajnar &amp; Zerovnik, <xref rid="embj201798358-bib-0073" ref-type="ref">2014</xref>). The ubiquitin labeled misfolded proteins are recognized by p62 which drives their oligomerization into aggregates (Seibenhener <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0083" ref-type="ref">2004</xref>; Bjorkoy <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0008" ref-type="ref">2005</xref>; Clausen <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0014" ref-type="ref">2010</xref>). Subsequently, p62 or other autophagy receptors present on the protein aggregates recruit LC3B and facilitate their autophagic degradation (Pankiv <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0072" ref-type="ref">2007</xref>; Lamark &amp; Johansen, <xref rid="embj201798358-bib-0052" ref-type="ref">2012</xref>). However, our understanding of this entire process is limited and the details of other molecular players that drive this process remain unknown.</p>
      <p>In this study, we identified TRIM16 as a key regulatory protein that mounts a comprehensive response to oxidative or proteotoxic stresses and facilitates the biogenesis and degradation of the protein aggregates (FigÂ <xref rid="embj201798358-fig-0009" ref-type="fig">9</xref>I). Through its twoâpronged regulation of NRF2 and autophagy, TRIM16 serves as proteostasis sentinel during oxidative or proteotoxic stresses. TRIM16 acts as a scaffold protein for both biogenesis and degradation of protein aggregates. Mechanistically, we show that under oxidative and proteotoxic stress conditions, TRIM16 upregulates and induces NRF2 signaling leading to increased cellular availability of ubiquitin system proteins and p62 for the assembly of protein aggregates (FigÂ <xref rid="embj201798358-fig-0009" ref-type="fig">9</xref>I). TRIM16 increases interaction between p62 and NRF2, most likely to activate NRF2. TRIM16 also enhances interaction between p62 and KEAP1 for sequestration and autophagic degradation of KEAP1. In addition, TRIM16 is present as oligomer on stressâinduced protein aggregates and facilitates ubiquitin, p62 and LC3B recruitment to the aggregates. TRIM16 is important for basal and proteotoxic stressâinduced autophagy. TRIM16 associates with ULK1 and ATG16L1 over the aggresomes. ULK1 promotes autophagosome initiation, and ATG16L1 facilitates the extension/elongation of the phagophore; hence, the presence of ULK1 and ATG16L1 over the aggresomes may assist in <italic>de novo</italic> autophagosome biogenesis leading to the autophagic sequestration and clearance of the aggresomes. We show that TRIM16 contributes to the autophagic degradation of the protein aggregates by increasing positional availability of Ub, p62, and LC3B (the autophagosome marker protein) over the aggregates (FigÂ <xref rid="embj201798358-fig-0009" ref-type="fig">9</xref>I). Taken together, we show that TRIM16 is a proâsurvival protein, which under stress conditions utilizes all its instruments (autophagy, NRF2âp62, and Ub system) to keep the cell healthy and fit (FigÂ <xref rid="embj201798358-fig-0009" ref-type="fig">9</xref>I).</p>
      <p>The fact that the misfolded protein aggregates never accumulate in the healthy cell is due to the quality control system of the cell which includes ubiquitinâproteasome system (UPS), chaperoneâmediated autophagy (CMA) and macroautophagy (Chen <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0012" ref-type="ref">2011</xref>). Mainly, UPS is the first line of defense for degradation of misfolded proteins; however, the misfolded proteins which escape this quality control system can form protein aggregates that in most cases is degraded by macroautophagy process (Kirkin <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0043" ref-type="ref">2009</xref>; Chen <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0012" ref-type="ref">2011</xref>). The initial event which tags the misfolded proteins for subsequent degradation by UPS or CMA or autophagy is the polyâubiquitination. The ubiquitin precursor proteins in human are encoded by <italic>Ubb</italic>,<italic> Ubc, UBA52,</italic> and <italic>RPS27A</italic> genes and <italic>Ubb</italic> and <italic>Ubc,</italic> are shown to be upregulated by oxidative and proteotoxic stresses (Bianchi <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0007" ref-type="ref">2015</xref>). We show that TRIM16 via NRF2 play a significant role in their upregulation. Further, a number of Ubâsystem genes which include E1 activation, E2 conjugation, and E3 ligation enzymes are upregulated by proteotoxic stress in TRIM16â and NRF2âdependent manner underscoring the importance of TRIM16 and NRF2 in misfolded protein ubiquitination. We show that NRF2 and its downstream genes <italic>Ubb</italic> and <italic>Ube2n</italic> are required for formation of aggresomes/ALIS and NRF2 is sufficient to complement the aggresome biogenesis defect of TRIM16âdepleted cells. Although NRF2 is an immensely studied transcription factor, its function in misfolded proteins ubiquitination and biogenesis of protein aggregates was never evidently shown before this study.</p>
      <p>Our data suggest that TRIM16 activates NRF2 in several ways. TRIM16 increases vicinity of NRF2 with p62, an event important for NRF2 activation. TRIM16 reduces NRF2 and KEAP1 interaction liberating NRF2 from the inhibitory complex. TRIM16 increases interaction between KEAP1 and p62, most likely for autophagic sequestration/degradation of KEAP1. TRIM16 decreases K48âlinked ubiquitination of NRF2 (maybe by blocking KEAP1 interaction with NRF2) and increases K63âlinked ubiquitination of NRF2. Both events can provide stability to NRF2 for its activation. The SPRY domain of TRIM16 is important for K63âlinked ubiquitination of NRF2, ubiquitin conjugation to misfolded proteins, and protein aggregate formation suggesting that K63âlinked ubiquitination is an important event associated with NRF2 stability and activation. Taken together, the data suggest that TRIM16 invokes several mechanisms to stabilize and activate NRF2.</p>
      <p>Understanding the molecular mechanisms of protein aggregation and their clearance will provide newer potential therapeutic targets for developing efficient therapies against proteinopathies. Many neurodegenerative diseases, including Alzheimer's, Parkinson's, amyotrophic lateral sclerosis (ALS), are caused by the misfolding and aggregation of proteins such as tau, alphaâsynuclein, superoxide dismutase 1 (SOD1), and TAR DNAâbinding proteinâ43 (TDPâ43; Lansbury &amp; Lashuel, <xref rid="embj201798358-bib-0054" ref-type="ref">2006</xref>). A recent study showed that TRIM16 interacts with TDPâ43 (Kim <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0037" ref-type="ref">2016</xref>), the protein which is identified as the major component of the neuronal cytoplasmic inclusion bodies deposited in ALS (Scotter <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0082" ref-type="ref">2015</xref>). Further studies are needed to understand the physiological relevance of this interaction in ALS. Growing evidence suggests the role of protein misfolding and aggregation in cancer (Scott &amp; Frydman, <xref rid="embj201798358-bib-0081" ref-type="ref">2003</xref>; Xu <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0095" ref-type="ref">2011</xref>). The cancer cells can maintain protein homeostasis due to intact or overactive protein aggregates turn over machinery and thus can survive in harsh oxidative stress conditions. The TRIM16âdepletion cripples these machinery leading to the accumulation of toxic misfolded proteins or aggregates intermediates and makes the cancer cell vulnerable to oxidative or proteotoxic stresses inÂ vitro and inÂ vivo (FigÂ <xref rid="embj201798358-fig-0007" ref-type="fig">7</xref>). Taken together, this work highlights the significance of TRIM16 in proteostasis and hints that therapeutic modulation of TRIM16 could be a potential strategy to treat proteinopathies including cancer.</p>
    </sec>
    <sec id="embj201798358-sec-0013">
      <title>Materials and Methods</title>
      <sec id="embj201798358-sec-0014">
        <title>Cell culture</title>
        <p>Cell lines were purchased from ATCC. HeLa (CCLâ2) and human embryonic kidney (HEK293T, CRLâ11268) were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum and penicillin/ streptomycin (10,000Â unit/ml). THPâ1 (TIBâ202) cells were grown in RPMIâ1640 (Gibco) media supplemented with 10% FBS, 5Â mM <sc>l</sc>âglutamine, glucose (5%), HEPES buffer, sodium pyruvate (1Â mM), penicillin/streptomycin (10,000Â units/ml).</p>
      </sec>
      <sec id="embj201798358-sec-0015">
        <title>Inhibitors and concentrations</title>
        <p>MG132 (10Â Î¼M or 20Â Î¼M, Sigma #C2211), puromycin (5Â Î¼g/ml, Sigma #P8833), H<sub>2</sub>O<sub>2</sub> (100â400Â Î¼M, Merck), As<sub>2</sub>O<sub>3</sub> (2.5 or 5Â Î¼M, Sigma #202673), bafilomycin A1 (300Â nM, Sigma # B1793 and Invivogen # tlrlâbaf1).</p>
      </sec>
      <sec id="embj201798358-sec-0016">
        <title>Plasmids, siRNA, and transfection</title>
        <p>GFPâpolyQ74 (#40262), GFPâp62 (#38277), GFPâNRF2 (#21549), GFPâKEAP1 (#28025), FlagâKEAP1 (#28023), MycâNRF2 (#21555), FlagâNRF2 (#36971), HAâK48 (#17605), HAâK63 (#17606), FlagâULK1 (#27636) were procured from Addgene. GFPâTRIM16 and FlagâTRIM16 were cloned as described previously (Chauhan <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0011" ref-type="ref">2016</xref>). MycâTRIM16, MycâTRIM16 deletion constructs, and HisâK63âUB were generated using Gateway cloning strategy as per standard protocol (Invitrogen).</p>
        <p>The siRNA for NRF2 and p62 were purchased from Sigma, and TRIM16, Ubb, Ube2n siRNA were from Dharmacon. For overexpression experiments, HEK293T cells were transfected using calcium phosphate method as per the manufacturer's instructions (Profection, Promega). Other cells are transfected using Effectene (Qiagen) or Viafect (Promega) or Interference (Polyplus) as per the manufacturer's instruction.</p>
      </sec>
      <sec id="embj201798358-sec-0017">
        <title>CRISPR knock out cell line</title>
        <p>The TRIM16 knockout cell line is generated using CRISPRâCAS9 technology and is described previously (Chauhan <italic>etÂ al</italic>, <xref rid="embj201798358-bib-0011" ref-type="ref">2016</xref>).</p>
      </sec>
      <sec id="embj201798358-sec-0018">
        <title>Western blotting</title>
        <p>The NPâ40 (Invitrogen #FNN0021) or radioimmunoprecipitation assay (RIPA) buffer (20Â mM Tris, pH 8.0; 1Â mM, EDTA; 0.5Â mM, EGTA; 0.1% sodium deoxycholate; 150Â mM NaCl; 1% IGEPAL (Sigma #I8896); 10% glycerol) supplemented with protease inhibitor cocktail (Roche) and 1Â mM PMSF was used to make cell lysates. Protein concentration was measured by BCA kit (Pierce). Protein lysates were separated on SDSâpolyacrylamide gel, transferred onto nitrocellulose membrane (BioâRad), and blocked for 1Â h in 5% skimmed milk. Subsequently, membranes were incubated in primary antibody overnight at 4Â°C, washed (3Ã PBS/PBST), and then incubated for 1Â h with HRPâconjugated secondary antibody (Promega). After washing with PBS/PBST (3Ã), the blots are developed using enhanced chemiluminescence system (Thermo Fisher). Densitometric analysis of Western blots was done using ImageJ software.</p>
        <p>Primary antibodies used in Western blotting with dilutions were as follows: Trim16 (Santa Cruz #SCâ79770; 1:1,000; Bethyl laboratories #A301â159A; 1:200), câMyc (Santa Cruz #SCâ40; 1:750), Î±âtubulin (Abcam #Ab7291; 1:5,000), p62 (BD #610832; 1:2,000), caspaseâ3 (Santa Cruz #SCâ7148; 1:750), PARP1 (CST #9542L; 1:1,000 and Santa Cruz #SCâ7150; 1:500), cleaved PARP1 (Santa Cruz #SCâ23461; 1:500), NRF2 (Abcam #ab62352; CSTâmAbÂ #12721S, 1:2,000), GFP (Abcam #Ab290; 1:5,000), actin (Abcam #ab6276; 1:5,000). Flag (Sigma #F1804; 1:1,000), LC3B (Sigma #L7543; 1:2,000), antiâmulti ubiquitin (MBL #D0583; 1:1,000) ATGâ16L (Sigma #SAB140760; 1:1,000), ULKâ1 (CST #8054S 1:1,000), HA (CST #3724S; 1:1,000), Keap1 (CST #8047S; 1:1,000), phosphoâp62 (MBL #PM074; 1:2,000), lamin B1 (CST #12586S; 1:1,000), K48 (CST #4289S; 1:1,000), and K63 (CST #5621S; 1:1,000), Hisâtag (CST #2365S; 1:1,000). HRPâconjugated secondary antibodies were purchased from Santa Cruz (1:2,000) or Promega (1:5,000).</p>
      </sec>
      <sec id="embj201798358-sec-0019">
        <title>Immunoprecipitation assay</title>
        <p>For immunoprecipitation assays, cells were lysed in NPâ40 lysis buffer (Thermo Fisher Scientific #FNN0021) supplemented with protease inhibitor/phosphatase inhibitor cocktails and 1Â M PMSF for 20Â min at 4Â°C and centrifuged. The supernatant was incubated with specific antibody at 4Â°C (2Â h to overnight) on tube rotator followed by incubation with Protein G Dynabeads (Invitrogen, #10004D) for 2Â h at 4Â°C. The beads were washed with iceâcold PBST (4Ã), and the proteins were eluted from washed beads by boiling for 5Â min in 2Ã Laemmli sample buffer and proceeded for Western blot analysis.</p>
      </sec>
      <sec id="embj201798358-sec-0020">
        <title>NiâNTA pullâdown assay</title>
        <p>HEKâ293T cells were transfected with desired plasmids. Next day, cells were lysed with lysis buffer containing 6Â M guanidine hydrochloride for 20Â min at 4Â°C and lysate were clarified at 12,000Â <italic>g</italic> for 15Â min. Meanwhile, 100Â Î¼l NiâNTA slurry corresponding to 50Â Î¼l beads (Qiagen #30210) was washed with lysis buffer. Then, 700Â Î¼l of cell lysate was incubated with 50Â Î¼l of 100% NiâNTA agarose beads for 3â4Â h. The beads were sedimented at 2,000Â <italic>g</italic>, followed by one time wash with lysis buffer and 4 times with 1Ã PBS. Proteins were eluted from agarose beads by boiling for 5Â min in 50Â Î¼l 2Ã Laemmli sample buffer and immediately processed for Western blot analysis.</p>
      </sec>
      <sec id="embj201798358-sec-0021">
        <title>Immunofluorescence and immunohistochemistry analysis</title>
        <p>About 10<sup>5</sup> cells were plated on a coverslip. The next day, cells were fixed in 4% paraformaldehyde for 10Â min, permeabilized with 0.1% saponin (or 0.1% Triton Xâ100) for 10Â min, followed by blocking with 1% BSA for 30Â min at room temperature (RT). Next, cells were incubated with primary antibody for 1Â h at RT, washed thrice with 1Ã PBS, followed by 1Â h incubation with Alexa fluorâconjugated secondary antibody. Cells were again washed thrice with 1Ã PBS, mounted (Prolong gold antifade, Invitrogen), airâdried, and visualized using Leica TCS SP5 confocal microscope.</p>
        <p>For immunohistochemistry (IHC), tumor tissue samples were harvested and preserved in 10% formalin buffer solution at room temperature. Tissues were processed for paraffin embedding, and multiple 5âÎ¼m sections were prepared using microtome. Briefly, slides were deparaffinized and hydrated with deionized water. Antigen retrieval was performed in acidic pH citrate buffer (Vector Lab #H3301) by incubating the slides in a steam cooker for 20Â min. Slides were kept for cooling and then washed twice with 1Ã PBS for 5Â min, followed by endogenous peroxidase quenching in 3% hydrogen peroxide (Merck) for 15Â min. Nonspecific binding was blocked by incubating the slides with horse serum (Vector Lab #PK7200) for 30Â min, followed by incubation with primary antibody KIâ67 (1:100) (Vector Lab #VPâRM04) at 4Â°C for overnight in a humidified chamber. Slides were then washed twice with PBST (0.1%) for 5Â min and incubated with biotinylated antiârabbit/mouse IgG secondary antibody (Vector Lab #PKâ7200) for 45Â min, followed by washing with PBST for 5Â min and treated with ABC reagent (Vector Lab #PKâ7200) for 30Â min at room temperature. 3,3â²âDiaminobenzidine (Vector Lab #SKâ4100) was used to detect the immunoreactivity. Slides were subsequently counterstained with hematoxylin (Sigma #MHS1), followed by washing with Scott's tap water (Sigma #S5134). Slides were then dehydrated through sequential alcohol grading, cleared in xylene, and mounted with permanent mounting media (Vector Lab #Hâ5000). Stained slides were observed under a Leica DM500 light microscope, and images were taken at 40Ã magnifications.</p>
        <p>Primary antibodies used in immunofluorescence experiments are ubiquitin (clone FK2 #MBL D058â3, 1:500), p62 (CST #5114, 1:100), LC3B (MBL #PM036; 1:500), Flag (Sigma #F1804, 1:500), GFP (Abcam #Ab290, 1:500); ULK1 (Santa Cruz #SC33182, 1:50), ATG16L (Abgent #AP1817, 1:25).</p>
      </sec>
      <sec id="embj201798358-sec-0022">
        <title>Soluble and insoluble protein fractionation</title>
        <p>Solubleâinsoluble proteins were fractionated using lysis buffer containing 50Â mM Tris (pH 8.0), 2% Triton Xâ100, 150Â mM NaCl, 1Â mM EDTA, 10% glycerol, protease inhibitor cocktail, and 1Â mM PMSF (Fujita &amp; Srinivasula, <xref rid="embj201798358-bib-0022" ref-type="ref">2011</xref>). After centrifugation, the supernatant was used as soluble fraction and the pellet was extracted in 1% SDS to obtain insoluble protein fraction.</p>
      </sec>
      <sec id="embj201798358-sec-0023">
        <title>Oligomerization assay</title>
        <p>The cells were seeded in 10âcm plates and treated with MG132 (20Â Î¼M) for 2Â h. Cells were lysed in PBS containing 0.5% Triton Xâ100, and the cell lysates were centrifuged at 6,797Â <italic>g</italic> for 15Â min at 4Â°C. Supernatants containing the soluble proteins were collected into new tubes (Triton Xâsoluble fractions). The Triton Xâ100âinsoluble pellets were washed with PBS twice and then suspended in 200Â Î¼l PBS. The pellets were then crossâlinked at room temperature for 30Â min by adding 2Â mM disuccinimidsuberate (DSS). The crossâlinked pellets were spun down at 6,797Â <italic>g</italic> for 15Â min and dissolved directly in nonâreducing Laemmli sample buffer.</p>
      </sec>
      <sec id="embj201798358-sec-0024">
        <title>Cycloheximide chase assay</title>
        <p>To determine the protein stability, cycloheximide chase experiments were performed, where cells were treated with cycloheximide (100Â Î¼g/ml) and harvested at indicated time point thereafter using lysis buffer. Further, the stability of the indicated proteins was determined by Western blot analysis as described elsewhere.</p>
      </sec>
      <sec id="embj201798358-sec-0025">
        <title>Clonogenic assay and MTT assay</title>
        <p>For clonogenic assay, 2,000 cells were seeded in a sixâwell plate in triplicates. After 2Â days, the cells were treated with indicated stress inducers and allowed to grow for 2â3Â weeks until the colonies from single cells were formed. Cells were fixed in methanol: acetic acid (3:1) for 5Â min at RT and stained with 0.5% crystal violet for 15Â min and washed with water. The pictures were taken with a digital camera.</p>
        <p>For MTT assays, 5,000Â cells were seeded in triplicate in 25âcm<sup>2</sup> flask and allowed to grow for 2Â days. The cells were treated with indicated stress inducers and the cells were allowed to grow for 5 more days. Subsequently, at each time point, media is removed, and cells were washed with PBS and treated with MTT (3â[4,5âdimethylthiazolylâ2â2,5âdiphenyltetrazolium bromide) (5Â mg/ml, Sigma) for 2Â h. The dye precipitates were dissolved in DMSO, and the absorbance was measured at 570Â nm.</p>
      </sec>
      <sec id="embj201798358-sec-0026">
        <title>AnnexinâV/Propidium Iodide staining</title>
        <p>Apoptosis was measured using AnnexinâV/PI doubleâstaining method as per manufacturer's instruction (eBiosciences #88800574). Briefly, cells were treated with indicated stress inducers. At indicated time, followed by washing with 1Ã PBS and trypsinized to obtain a singleâcell suspension, next, 10<sup>5</sup>Â cells/ml were suspended in 100Â Î¼l binding buffer along with 5Â Î¼l AnnexinâV fluorescein isothiocyanate and 5Â Î¼l propidium iodide for 30Â min at room temperature, followed by acquisition on FACS Calibur (Beckton &amp; Dickinson). The results were analyzed using Cell Quest Pro software.</p>
      </sec>
      <sec id="embj201798358-sec-0027">
        <title>RNA isolation and quantitative realâtime PCR</title>
        <p>RNA isolation and qRTâPCR are performed exactly as described previously (Chauhan &amp; Boyd, <xref rid="embj201798358-bib-0010" ref-type="ref">2012</xref>). Briefly, total RNA was extracted using Trizol reagent according to manufacturer's protocols (Invitrogen). 2Â Î¼g of RNA was used for reverse transcription using highâcapacity DNA reverse transcription kit (Applied Biosystems #4368813), and qRTâPCR was performed using Power SYBR green PCR master mix (Applied Biosystems #4367659) according to manufacturer's protocols.</p>
      </sec>
      <sec id="embj201798358-sec-0028">
        <title>Animal experiments</title>
        <p>The experimental protocols used in this study were approved by the Institutional Animal Ethical Review Committee. Sixâ to eightâweekâold BALB/Cânude female mice weighing 16â20Â g were maintained under pathogenâfree conditions in the animal house. The tumor xenograft model was established by subcutaneous injection of 10<sup>7</sup> cells along with Matrigel (BD Corning), into right and left lower flanks. Animals were divided randomly into two groups (6 mice each) and after 15Â days of injections (average tumor volume of ~100â120Â mm<sup>3</sup>), mice were intraperitoneally injected with PBS or As<sub>2</sub>O<sub>3</sub> (5Â mg/kg). Tumor volume was measured every alternative day till the mice were sacrificed. Tumors were isolated and processed for Western blotting or IHC.</p>
      </sec>
    </sec>
    <sec id="embj201798358-sec-0030">
      <title>Author contributions</title>
      <p>Santosh C and KKJ designed the experiments. KKJ, SPK, SM, PN, BD, PKS, AA, Swati C, and Santosh C performed the experiments. Santosh C, Swati C, and SS supervised experimental work. Santosh C, Swati C, GHS, and SKR wrote the article. All authors contributed to data analysis and commented on the manuscript.</p>
    </sec>
    <sec id="embj201798358-sec-0031">
      <title>Conflict of interest</title>
      <p>The authors declare that they have no conflict of interest.</p>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Supporting information</title>
      <supplementary-material content-type="local-data"/>
      <supplementary-material content-type="local-data" id="embj201798358-sup-0001">
        <caption>
          <p>Appendix</p>
        </caption>
        <media xlink:href="EMBJ-37-e98358-s001.pdf">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="embj201798358-sup-0002">
        <caption>
          <p>Expanded View Figures PDF</p>
        </caption>
        <media xlink:href="EMBJ-37-e98358-s002.pdf">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="embj201798358-sup-0012">
        <caption>
          <p>Source Data for Expanded View</p>
        </caption>
        <media xlink:href="EMBJ-37-e98358-s012.zip">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data">
        <caption>
          <p>Review Process File</p>
        </caption>
        <media xlink:href="EMBJ-37-e98358-s013.pdf">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="embj201798358-supp-data-0001">
        <caption>
          <p>Source Data for FigureÂ 1</p>
        </caption>
        <media xlink:href="EMBJ-37-e98358-s003.pdf">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="embj201798358-supp-data-0002">
        <caption>
          <p>Source Data for FigureÂ 2</p>
        </caption>
        <media xlink:href="EMBJ-37-e98358-s004.pdf">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="embj201798358-supp-data-0003">
        <caption>
          <p>Source Data for FigureÂ 3</p>
        </caption>
        <media xlink:href="EMBJ-37-e98358-s005.pdf">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="embj201798358-supp-data-0004">
        <caption>
          <p>Source Data for FigureÂ 4</p>
        </caption>
        <media xlink:href="EMBJ-37-e98358-s006.pdf">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="embj201798358-supp-data-0005">
        <caption>
          <p>Source Data for FigureÂ 5</p>
        </caption>
        <media xlink:href="EMBJ-37-e98358-s007.pdf">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="embj201798358-supp-data-0006">
        <caption>
          <p>Source Data for FigureÂ 6</p>
        </caption>
        <media xlink:href="EMBJ-37-e98358-s008.pdf">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="embj201798358-supp-data-0007">
        <caption>
          <p>Source Data for FigureÂ 7</p>
        </caption>
        <media xlink:href="EMBJ-37-e98358-s009.pdf">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="embj201798358-supp-data-0008">
        <caption>
          <p>Source Data for FigureÂ 8</p>
        </caption>
        <media xlink:href="EMBJ-37-e98358-s010.pdf">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="embj201798358-supp-data-0009">
        <caption>
          <p>Source Data for FigureÂ 9</p>
        </caption>
        <media xlink:href="EMBJ-37-e98358-s011.pdf">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack id="embj201798358-sec-0029">
      <title>Acknowledgements</title>
      <p>This work is supported by the Wellcome Trust/Department of Biotechnology (DBT) India Alliance (IA/I/15/2/502071) fellowship, ILS core funding (Department of Biotechnology, India), and Early Career Reward (SERB, ECR/2016/000478) to Santosh Chauhan. Subhash Mehto and Swati Chauhan are supported by fellowship from SERB (NPDF, PDF/2016/001697) and DST (SR/WOSâA/LSâ9/2016). We gratefully acknowledge the guidance, reagents, and support provided by Dr. Vojo Deretic (University of New Mexico, USA), Dr. Terje Johansen (University of Tromso, Norway), and Dr Rupesh Das (ILS, India) during the course of this study. We acknowledge the technical assistance of Mr. Kshitish Rout and Mr.Â Bhabani Sahoo (Microscopy facility). We gratefully acknowledge the support of ILS central facilities (Animal, Microscopy, FACS, and Sequencing).</p>
    </ack>
    <ref-list content-type="cited-references" id="embj201798358-bibl-0001">
      <title>References</title>
      <ref id="embj201798358-bib-0001">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0001">
<string-name>
<surname>Amm</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Sommer</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Wolf</surname>
<given-names>DH</given-names>
</string-name> (<year>2014</year>) <article-title>Protein quality control and elimination of protein waste: the role of the ubiquitinâproteasome system</article-title>. <source xml:lang="en">Biochem Biophys Acta</source>
<volume>1843</volume>: <fpage>182</fpage>â<lpage>196</lpage>
<pub-id pub-id-type="pmid">23850760</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0002">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0002">
<string-name>
<surname>Arrasate</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Mitra</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Schweitzer</surname>
<given-names>ES</given-names>
</string-name>, <string-name>
<surname>Segal</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Finkbeiner</surname>
<given-names>S</given-names>
</string-name> (<year>2004</year>) <article-title>Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death</article-title>. <source xml:lang="en">Nature</source>
<volume>431</volume>: <fpage>805</fpage>â<lpage>810</lpage>
<pub-id pub-id-type="pmid">15483602</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0003">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0003">
<string-name>
<surname>Bao</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Gu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Ta</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>Z</given-names>
</string-name> (<year>2016</year>) <article-title>Induction of autophagy by the MG132 proteasome inhibitor is associated with endoplasmic reticulum stress in MCF7 cells</article-title>. <source xml:lang="en">Mol Med Rep</source>
<volume>13</volume>: <fpage>796</fpage>â<lpage>804</lpage>
<pub-id pub-id-type="pmid">26648402</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0004">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0004">
<string-name>
<surname>Bell</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Malyukova</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Holien</surname>
<given-names>JK</given-names>
</string-name>, <string-name>
<surname>Koach</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Parker</surname>
<given-names>MW</given-names>
</string-name>, <string-name>
<surname>Kavallaris</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Marshall</surname>
<given-names>GM</given-names>
</string-name>, <string-name>
<surname>Cheung</surname>
<given-names>BB</given-names>
</string-name> (<year>2012</year>) <article-title>TRIM16 acts as an E3 ubiquitin ligase and can heterodimerize with other TRIM family members</article-title>. <source xml:lang="en">PLoS One</source>
<volume>7</volume>: <fpage>e37470</fpage>
<pub-id pub-id-type="pmid">22629402</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0005">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0005">
<string-name>
<surname>Bershtein</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Mu</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Serohijos</surname>
<given-names>AW</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Shakhnovich</surname>
<given-names>EI</given-names>
</string-name> (<year>2013</year>) <article-title>Protein quality control acts on folding intermediates to shape the effects of mutations on organismal fitness</article-title>. <source xml:lang="en">Mol Cell</source>
<volume>49</volume>: <fpage>133</fpage>â<lpage>144</lpage>
<pub-id pub-id-type="pmid">23219534</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0006">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0006">
<string-name>
<surname>Bersuker</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Brandeis</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kopito</surname>
<given-names>RR</given-names>
</string-name> (<year>2016</year>) <article-title>Protein misfolding specifies recruitment to cytoplasmic inclusion bodies</article-title>. <source xml:lang="en">J Cell Biol</source>
<volume>213</volume>: <fpage>229</fpage>â<lpage>241</lpage>
<pub-id pub-id-type="pmid">27114501</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0007">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0007">
<string-name>
<surname>Bianchi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Giacomini</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Crinelli</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Radici</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Carloni</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Magnani</surname>
<given-names>M</given-names>
</string-name> (<year>2015</year>) <article-title>Dynamic transcription of ubiquitin genes under basal and stressful conditions and new insights into the multiple UBC transcript variants</article-title>. <source xml:lang="en">Gene</source>
<volume>573</volume>: <fpage>100</fpage>â<lpage>109</lpage>
<pub-id pub-id-type="pmid">26172870</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0008">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0008">
<string-name>
<surname>Bjorkoy</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Lamark</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Brech</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Outzen</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Perander</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Overvatn</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Stenmark</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Johansen</surname>
<given-names>T</given-names>
</string-name> (<year>2005</year>) <article-title>p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtinâinduced cell death</article-title>. <source xml:lang="en">J Cell Biol</source>
<volume>171</volume>: <fpage>603</fpage>â<lpage>614</lpage>
<pub-id pub-id-type="pmid">16286508</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0009">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0009">
<string-name>
<surname>Bjorkoy</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Lamark</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Johansen</surname>
<given-names>T</given-names>
</string-name> (<year>2006</year>) <article-title>p62/SQSTM1: a missing link between protein aggregates and the autophagy machinery</article-title>. <source xml:lang="en">Autophagy</source>
<volume>2</volume>: <fpage>138</fpage>â<lpage>139</lpage>
<pub-id pub-id-type="pmid">16874037</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0010">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0010">
<string-name>
<surname>Chauhan</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Boyd</surname>
<given-names>DD</given-names>
</string-name> (<year>2012</year>) <article-title>Regulation of uâPAR gene expression by H2A.Z is modulated by the MEKâERK/APâ1 pathway</article-title>. <source xml:lang="en">Nucleic Acids Res</source>
<volume>40</volume>: <fpage>600</fpage>â<lpage>613</lpage>
<pub-id pub-id-type="pmid">21937508</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0011">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0011">
<string-name>
<surname>Chauhan</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kumar</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Jain</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ponpuak</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Mudd</surname>
<given-names>MH</given-names>
</string-name>, <string-name>
<surname>Kimura</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Choi</surname>
<given-names>SW</given-names>
</string-name>, <string-name>
<surname>Peters</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Mandell</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Bruun</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Johansen</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Deretic</surname>
<given-names>V</given-names>
</string-name> (<year>2016</year>) <article-title>TRIMs and Galectins Globally Cooperate and TRIM16 and Galectinâ3 Coâdirect Autophagy in Endomembrane Damage Homeostasis</article-title>. <source xml:lang="en">Dev Cell</source>
<volume>39</volume>: <fpage>13</fpage>â<lpage>27</lpage>
<pub-id pub-id-type="pmid">27693506</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0012">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0012">
<string-name>
<surname>Chen</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Retzlaff</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Roos</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Frydman</surname>
<given-names>J</given-names>
</string-name> (<year>2011</year>) <article-title>Cellular strategies of protein quality control</article-title>. <source xml:lang="en">Cold Spring Harb Perspect Biol</source>
<volume>3</volume>: <fpage>a004374</fpage>
<pub-id pub-id-type="pmid">21746797</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0013">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0013">
<string-name>
<surname>Choi</surname>
<given-names>KS</given-names>
</string-name>, <string-name>
<surname>Choi</surname>
<given-names>HJ</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>JK</given-names>
</string-name>, <string-name>
<surname>Im</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Jeong</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Park</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>IK</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>YM</given-names>
</string-name>, <string-name>
<surname>Kwon</surname>
<given-names>YG</given-names>
</string-name> (<year>2016</year>) <article-title>The endothelial E3 ligase HECW2 promotes endothelial cell junctions by increasing AMOTL1 protein stability via K63âlinked ubiquitination</article-title>. <source xml:lang="en">Cell Signal</source>
<volume>28</volume>: <fpage>1642</fpage>â<lpage>1651</lpage>
<pub-id pub-id-type="pmid">27498087</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0014">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0014">
<string-name>
<surname>Clausen</surname>
<given-names>TH</given-names>
</string-name>, <string-name>
<surname>Lamark</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Isakson</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Finley</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Larsen</surname>
<given-names>KB</given-names>
</string-name>, <string-name>
<surname>Brech</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Overvatn</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Stenmark</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Bjorkoy</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Simonsen</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Johansen</surname>
<given-names>T</given-names>
</string-name> (<year>2010</year>) <article-title>p62/SQSTM1 and ALFY interact to facilitate the formation of p62 bodies/ALIS and their degradation by autophagy</article-title>. <source xml:lang="en">Autophagy</source>
<volume>6</volume>: <fpage>330</fpage>â<lpage>344</lpage>
<pub-id pub-id-type="pmid">20168092</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0015">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0015">
<string-name>
<surname>Copple</surname>
<given-names>IM</given-names>
</string-name>, <string-name>
<surname>Lister</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Obeng</surname>
<given-names>AD</given-names>
</string-name>, <string-name>
<surname>Kitteringham</surname>
<given-names>NR</given-names>
</string-name>, <string-name>
<surname>Jenkins</surname>
<given-names>RE</given-names>
</string-name>, <string-name>
<surname>Layfield</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Foster</surname>
<given-names>BJ</given-names>
</string-name>, <string-name>
<surname>Goldring</surname>
<given-names>CE</given-names>
</string-name>, <string-name>
<surname>Park</surname>
<given-names>BK</given-names>
</string-name> (<year>2010</year>) <article-title>Physical and functional interaction of sequestosome 1 with Keap1 regulates the Keap1âNrf2 cell defense pathway</article-title>. <source xml:lang="en">J Biol Chem</source>
<volume>285</volume>: <fpage>16782</fpage>â<lpage>16788</lpage>
<pub-id pub-id-type="pmid">20378532</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0016">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0016">
<string-name>
<surname>Cui</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Bai</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Luo</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Miao</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Cai</surname>
<given-names>L</given-names>
</string-name> (<year>2013</year>) <article-title>Preventive and therapeutic effects of MG132 by activating Nrf2âARE signaling pathway on oxidative stressâinduced cardiovascular and renal injury</article-title>. <source xml:lang="en">Oxid Med Cell Longev</source>
<volume>2013</volume>: <fpage>306073</fpage>
<pub-id pub-id-type="pmid">23533688</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0017">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0017">
<string-name>
<surname>D'Cruz</surname>
<given-names>AA</given-names>
</string-name>, <string-name>
<surname>Babon</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Norton</surname>
<given-names>RS</given-names>
</string-name>, <string-name>
<surname>Nicola</surname>
<given-names>NA</given-names>
</string-name>, <string-name>
<surname>Nicholson</surname>
<given-names>SE</given-names>
</string-name> (<year>2013</year>) <article-title>Structure and function of the SPRY/B30.2 domain proteins involved in innate immunity</article-title>. <source xml:lang="en">Protein Sci</source>
<volume>22</volume>: <fpage>1</fpage>â<lpage>10</lpage>
</mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0018">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0018">
<string-name>
<surname>Dodson</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Redmann</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Rajasekaran</surname>
<given-names>NS</given-names>
</string-name>, <string-name>
<surname>DarleyâUsmar</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>J</given-names>
</string-name> (<year>2015</year>) <article-title>KEAP1âNRF2 signalling and autophagy in protection against oxidative and reductive proteotoxicity</article-title>. <source xml:lang="en">Biochem J</source>
<volume>469</volume>: <fpage>347</fpage>â<lpage>355</lpage>
<pub-id pub-id-type="pmid">26205490</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0019">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0019">
<string-name>
<surname>Douglas</surname>
<given-names>PM</given-names>
</string-name>, <string-name>
<surname>Treusch</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ren</surname>
<given-names>HY</given-names>
</string-name>, <string-name>
<surname>Halfmann</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Duennwald</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>Lindquist</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Cyr</surname>
<given-names>DM</given-names>
</string-name> (<year>2008</year>) <article-title>Chaperoneâdependent amyloid assembly protects cells from prion toxicity</article-title>. <source xml:lang="en">Proc Natl Acad Sci USA</source>
<volume>105</volume>: <fpage>7206</fpage>â<lpage>7211</lpage>
<pub-id pub-id-type="pmid">18480252</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0020">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0020">
<string-name>
<surname>Erpapazoglou</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Walker</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>HaguenauerâTsapis</surname>
<given-names>R</given-names>
</string-name> (<year>2014</year>) <article-title>Versatile roles of k63âlinked ubiquitin chains in trafficking</article-title>. <source xml:lang="en">Cells</source>
<volume>3</volume>: <fpage>1027</fpage>â<lpage>1088</lpage>
<pub-id pub-id-type="pmid">25396681</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0021">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0021">
<string-name>
<surname>Fraiberg</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Elazar</surname>
<given-names>Z</given-names>
</string-name> (<year>2016</year>) <article-title>A TRIM16âGalactin 3 complex mediates autophagy of damaged endomembranes</article-title>. <source xml:lang="en">Dev Cell</source>
<volume>39</volume>: <fpage>1</fpage>â<lpage>2</lpage>
<pub-id pub-id-type="pmid">27728777</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0022">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0022">
<string-name>
<surname>Fujita</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Srinivasula</surname>
<given-names>SM</given-names>
</string-name> (<year>2011</year>) <article-title>TLR4âmediated autophagy in macrophages is a p62âdependent type of selective autophagy of aggresomeâlike induced structures (ALIS)</article-title>. <source xml:lang="en">Autophagy</source>
<volume>7</volume>: <fpage>552</fpage>â<lpage>554</lpage>
<pub-id pub-id-type="pmid">21412052</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0023">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0023">
<string-name>
<surname>Gal</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Strom</surname>
<given-names>AL</given-names>
</string-name>, <string-name>
<surname>Kwinter</surname>
<given-names>DM</given-names>
</string-name>, <string-name>
<surname>Kilty</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Shi</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Fu</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Wooten</surname>
<given-names>MW</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>H</given-names>
</string-name> (<year>2009</year>) <article-title>Sequestosome 1/p62 links familial ALS mutant SOD1 to LC3 via an ubiquitinâindependent mechanism</article-title>. <source xml:lang="en">J Neurochem</source>
<volume>111</volume>: <fpage>1062</fpage>â<lpage>1073</lpage>
<pub-id pub-id-type="pmid">19765191</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0024">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0024">
<string-name>
<surname>Goldberg</surname>
<given-names>AL</given-names>
</string-name> (<year>2003</year>) <article-title>Protein degradation and protection against misfolded or damaged proteins</article-title>. <source xml:lang="en">Nature</source>
<volume>426</volume>: <fpage>895</fpage>â<lpage>899</lpage>
<pub-id pub-id-type="pmid">14685250</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0025">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0025">
<string-name>
<surname>Hara</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Nakamura</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Matsui</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Yamamoto</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Nakahara</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>SuzukiâMigishima</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Yokoyama</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Mishima</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Saito</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Okano</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Mizushima</surname>
<given-names>N</given-names>
</string-name> (<year>2006</year>) <article-title>Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice</article-title>. <source xml:lang="en">Nature</source>
<volume>441</volume>: <fpage>885</fpage>â<lpage>889</lpage>
<pub-id pub-id-type="pmid">16625204</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0026">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0026">
<string-name>
<surname>Hatakeyama</surname>
<given-names>S</given-names>
</string-name> (<year>2017</year>) <article-title>TRIM family proteins: roles in autophagy, immunity, and carcinogenesis</article-title>. <source xml:lang="en">Trends Biochem Sci</source>
<volume>42</volume>: <fpage>297</fpage>â<lpage>311</lpage>
<pub-id pub-id-type="pmid">28118948</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0027">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0027">
<string-name>
<surname>Hirose</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Iwabuchi</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Shimada</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Kiyanagi</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Iwahara</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Nakayama</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Daida</surname>
<given-names>H</given-names>
</string-name> (<year>2011</year>) <article-title>Different responses to oxidized lowâdensity lipoproteins in human polarized macrophages</article-title>. <source xml:lang="en">Lipids Health Dis</source>
<volume>10</volume>: <fpage>1</fpage>
</mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0028">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0028">
<string-name>
<surname>Ichimura</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Waguri</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Sou</surname>
<given-names>YS</given-names>
</string-name>, <string-name>
<surname>Kageyama</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Hasegawa</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Ishimura</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Saito</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Kouno</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Fukutomi</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Hoshii</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Hirao</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Takagi</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Mizushima</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Motohashi</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Yoshimori</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Tanaka</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Yamamoto</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Komatsu</surname>
<given-names>M</given-names>
</string-name> (<year>2013</year>) <article-title>Phosphorylation of p62 activates the Keap1âNrf2 pathway during selective autophagy</article-title>. <source xml:lang="en">Mol Cell</source>
<volume>51</volume>: <fpage>618</fpage>â<lpage>631</lpage>
<pub-id pub-id-type="pmid">24011591</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0029">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0029">
<string-name>
<surname>Jackson</surname>
<given-names>MP</given-names>
</string-name>, <string-name>
<surname>Hewitt</surname>
<given-names>EW</given-names>
</string-name> (<year>2016</year>) <article-title>Cellular proteostasis: degradation of misfolded proteins by lysosomes</article-title>. <source xml:lang="en">Essays Biochem</source>
<volume>60</volume>: <fpage>173</fpage>â<lpage>180</lpage>
<pub-id pub-id-type="pmid">27744333</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0030">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0030">
<string-name>
<surname>Jain</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Lamark</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Sjottem</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Larsen</surname>
<given-names>KB</given-names>
</string-name>, <string-name>
<surname>Awuh</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Overvatn</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>McMahon</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hayes</surname>
<given-names>JD</given-names>
</string-name>, <string-name>
<surname>Johansen</surname>
<given-names>T</given-names>
</string-name> (<year>2010</year>) <article-title>p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response elementâdriven gene transcription</article-title>. <source xml:lang="en">J Biol Chem</source>
<volume>285</volume>: <fpage>22576</fpage>â<lpage>22591</lpage>
<pub-id pub-id-type="pmid">20452972</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0031">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0031">
<string-name>
<surname>Jaramillo</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>DD</given-names>
</string-name> (<year>2013</year>) <article-title>The emerging role of the Nrf2âKeap1 signaling pathway in cancer</article-title>. <source xml:lang="en">Genes Dev</source>
<volume>27</volume>: <fpage>2179</fpage>â<lpage>2191</lpage>
<pub-id pub-id-type="pmid">24142871</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0032">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0032">
<string-name>
<surname>Jiang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Kinch</surname>
<given-names>LN</given-names>
</string-name>, <string-name>
<surname>Brautigam</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Du</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Grishin</surname>
<given-names>NV</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>ZJ</given-names>
</string-name> (<year>2012</year>) <article-title>Ubiquitinâinduced oligomerization of the RNA sensors RIGâI and MDA5 activates antiviral innate immune response</article-title>. <source xml:lang="en">Immunity</source>
<volume>36</volume>: <fpage>959</fpage>â<lpage>973</lpage>
<pub-id pub-id-type="pmid">22705106</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0033">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0033">
<string-name>
<surname>Johansen</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Lamark</surname>
<given-names>T</given-names>
</string-name> (<year>2011</year>) <article-title>Selective autophagy mediated by autophagic adapter proteins</article-title>. <source xml:lang="en">Autophagy</source>
<volume>7</volume>: <fpage>279</fpage>â<lpage>296</lpage>
<pub-id pub-id-type="pmid">21189453</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0034">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0034">
<string-name>
<surname>Johnston</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Ward</surname>
<given-names>CL</given-names>
</string-name>, <string-name>
<surname>Kopito</surname>
<given-names>RR</given-names>
</string-name> (<year>1998</year>) <article-title>Aggresomes: a cellular response to misfolded proteins</article-title>. <source xml:lang="en">J Cell Biol</source>
<volume>143</volume>: <fpage>1883</fpage>â<lpage>1898</lpage>
<pub-id pub-id-type="pmid">9864362</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0035">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0035">
<string-name>
<surname>Johnston</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Illing</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>Kopito</surname>
<given-names>RR</given-names>
</string-name> (<year>2002</year>) <article-title>Cytoplasmic dynein/dynactin mediates the assembly of aggresomes</article-title>. <source xml:lang="en">Cell Motil Cytoskeleton</source>
<volume>53</volume>: <fpage>26</fpage>â<lpage>38</lpage>
<pub-id pub-id-type="pmid">12211113</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0036">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0036">
<string-name>
<surname>Kansanen</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Kuosmanen</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Leinonen</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Levonen</surname>
<given-names>AL</given-names>
</string-name> (<year>2013</year>) <article-title>The Keap1âNrf2 pathway: mechanisms of activation and dysregulation in cancer</article-title>. <source xml:lang="en">Redox Biol</source>
<volume>1</volume>: <fpage>45</fpage>â<lpage>49</lpage>
<pub-id pub-id-type="pmid">24024136</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0037">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0037">
<string-name>
<surname>Kim</surname>
<given-names>PY</given-names>
</string-name>, <string-name>
<surname>Tan</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Trahair</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Haber</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Norris</surname>
<given-names>MD</given-names>
</string-name>, <string-name>
<surname>Marshall</surname>
<given-names>GM</given-names>
</string-name>, <string-name>
<surname>Cheung</surname>
<given-names>BB</given-names>
</string-name> (<year>2016</year>) <article-title>High TDP43 expression is required for TRIM16âinduced inhibition of cancer cell growth and correlated with good prognosis of neuroblastoma and breast cancer patients</article-title>. <source xml:lang="en">Cancer Lett</source>
<volume>374</volume>: <fpage>315</fpage>â<lpage>323</lpage>
<pub-id pub-id-type="pmid">26902425</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0038">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0038">
<string-name>
<surname>Kimura</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Jain</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Choi</surname>
<given-names>SW</given-names>
</string-name>, <string-name>
<surname>Mandell</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Schroder</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Johansen</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Deretic</surname>
<given-names>V</given-names>
</string-name> (<year>2015</year>) <article-title>TRIMâmediated precision autophagy targets cytoplasmic regulators of innate immunity</article-title>. <source xml:lang="en">J Cell Biol</source>
<volume>210</volume>: <fpage>973</fpage>â<lpage>989</lpage>
<pub-id pub-id-type="pmid">26347139</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0039">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0039">
<string-name>
<surname>Kimura</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Jain</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Choi</surname>
<given-names>SW</given-names>
</string-name>, <string-name>
<surname>Mandell</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Johansen</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Deretic</surname>
<given-names>V</given-names>
</string-name> (<year>2016a</year>) <article-title>TRIMâdirected selective autophagy regulates immune activation</article-title>. <source xml:lang="en">Autophagy</source>
<volume>13</volume>: <fpage>989</fpage>â<lpage>990</lpage>
</mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0040">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0040">
<string-name>
<surname>Kimura</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Mandell</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Deretic</surname>
<given-names>V</given-names>
</string-name> (<year>2016b</year>) <article-title>Precision autophagy directed by receptor regulators â emerging examples within the TRIM family</article-title>. <source xml:lang="en">J Cell Sci</source>
<volume>129</volume>: <fpage>881</fpage>â<lpage>891</lpage>
<pub-id pub-id-type="pmid">26906420</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0041">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0041">
<string-name>
<surname>Kimura</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Jain</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Choi</surname>
<given-names>SW</given-names>
</string-name>, <string-name>
<surname>Mandell</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Johansen</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Deretic</surname>
<given-names>V</given-names>
</string-name> (<year>2017a</year>) <article-title>TRIMâdirected selective autophagy regulates immune activation</article-title>. <source xml:lang="en">Autophagy</source>
<volume>13</volume>: <fpage>989</fpage>â<lpage>990</lpage>
<pub-id pub-id-type="pmid">26983397</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0042">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0042">
<string-name>
<surname>Kimura</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Jia</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kumar</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Choi</surname>
<given-names>SW</given-names>
</string-name>, <string-name>
<surname>Gu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Mudd</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Dupont</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Peters</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Farzam</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Jain</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Lidke</surname>
<given-names>KA</given-names>
</string-name>, <string-name>
<surname>Adams</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Johansen</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Deretic</surname>
<given-names>V</given-names>
</string-name> (<year>2017b</year>) <article-title>Dedicated SNAREs and specialized TRIM cargo receptors mediate secretory autophagy</article-title>. <source xml:lang="en">EMBO J</source>
<volume>36</volume>: <fpage>42</fpage>â<lpage>60</lpage>
<pub-id pub-id-type="pmid">27932448</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0043">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0043">
<string-name>
<surname>Kirkin</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>McEwan</surname>
<given-names>DG</given-names>
</string-name>, <string-name>
<surname>Novak</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Dikic</surname>
<given-names>I</given-names>
</string-name> (<year>2009</year>) <article-title>A role for ubiquitin in selective autophagy</article-title>. <source xml:lang="en">Mol Cell</source>
<volume>34</volume>: <fpage>259</fpage>â<lpage>269</lpage>
<pub-id pub-id-type="pmid">19450525</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0044">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0044">
<string-name>
<surname>Klionsky</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Abdelmohsen</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Abe</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Abedin</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Abeliovich</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Acevedo Arozena</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Adachi</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Adams</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Adams</surname>
<given-names>PD</given-names>
</string-name>, <string-name>
<surname>Adeli</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Adhihetty</surname>
<given-names>PJ</given-names>
</string-name>, <string-name>
<surname>Adler</surname>
<given-names>SG</given-names>
</string-name>, <string-name>
<surname>Agam</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Agarwal</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Aghi</surname>
<given-names>MK</given-names>
</string-name>, <string-name>
<surname>Agnello</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Agostinis</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Aguilar</surname>
<given-names>PV</given-names>
</string-name>, <string-name>
<surname>AguirreâGhiso</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Airoldi</surname>
<given-names>EM</given-names>
</string-name>
<italic>etÂ al</italic> (<year>2016</year>) <article-title>Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)</article-title>. <source xml:lang="en">Autophagy</source>
<volume>12</volume>: <fpage>1</fpage>â<lpage>222</lpage>
<pub-id pub-id-type="pmid">26799652</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0045">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0045">
<string-name>
<surname>Komatsu</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Waguri</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Chiba</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Murata</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Iwata</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Tanida</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Ueno</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Koike</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Uchiyama</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Kominami</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Tanaka</surname>
<given-names>K</given-names>
</string-name> (<year>2006</year>) <article-title>Loss of autophagy in the central nervous system causes neurodegeneration in mice</article-title>. <source xml:lang="en">Nature</source>
<volume>441</volume>: <fpage>880</fpage>â<lpage>884</lpage>
<pub-id pub-id-type="pmid">16625205</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0046">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0046">
<string-name>
<surname>Komatsu</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ueno</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Waguri</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Uchiyama</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Kominami</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Tanaka</surname>
<given-names>K</given-names>
</string-name> (<year>2007a</year>) <article-title>Constitutive autophagy: vital role in clearance of unfavorable proteins in neurons</article-title>. <source xml:lang="en">Cell Death Differ</source>
<volume>14</volume>: <fpage>887</fpage>â<lpage>894</lpage>
<pub-id pub-id-type="pmid">17332773</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0047">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0047">
<string-name>
<surname>Komatsu</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Waguri</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Koike</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Sou</surname>
<given-names>YS</given-names>
</string-name>, <string-name>
<surname>Ueno</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Hara</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Mizushima</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Iwata</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Ezaki</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Murata</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Hamazaki</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Nishito</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Iemura</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Natsume</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Yanagawa</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Uwayama</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Warabi</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Yoshida</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Ishii</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kobayashi</surname>
<given-names>A</given-names>
</string-name>
<italic>etÂ al</italic> (<year>2007b</year>) <article-title>Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagyâdeficient mice</article-title>. <source xml:lang="en">Cell</source>
<volume>131</volume>: <fpage>1149</fpage>â<lpage>1163</lpage>
<pub-id pub-id-type="pmid">18083104</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0048">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0048">
<string-name>
<surname>Komatsu</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kurokawa</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Waguri</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Taguchi</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Kobayashi</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ichimura</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Sou</surname>
<given-names>YS</given-names>
</string-name>, <string-name>
<surname>Ueno</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Sakamoto</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Tong</surname>
<given-names>KI</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Nishito</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Iemura</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Natsume</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Ueno</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kominami</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Motohashi</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Tanaka</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Yamamoto</surname>
<given-names>M</given-names>
</string-name> (<year>2010</year>) <article-title>The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1</article-title>. <source xml:lang="en">Nat Cell Biol</source>
<volume>12</volume>: <fpage>213</fpage>â<lpage>223</lpage>
<pub-id pub-id-type="pmid">20173742</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0049">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0049">
<string-name>
<surname>Kraft</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Peter</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hofmann</surname>
<given-names>K</given-names>
</string-name> (<year>2010</year>) <article-title>Selective autophagy: ubiquitinâmediated recognition and beyond</article-title>. <source xml:lang="en">Nat Cell Biol</source>
<volume>12</volume>: <fpage>836</fpage>â<lpage>841</lpage>
<pub-id pub-id-type="pmid">20811356</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0050">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0050">
<string-name>
<surname>Kumar</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Chauhan</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Jain</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ponpuak</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Choi</surname>
<given-names>SW</given-names>
</string-name>, <string-name>
<surname>Mudd</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Peters</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Mandell</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Johansen</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Deretic</surname>
<given-names>V</given-names>
</string-name> (<year>2017</year>) <article-title>Galectins and TRIMs directly interact and orchestrate autophagic response to endomembrane damage</article-title>. <source xml:lang="en">Autophagy</source>
<volume>13</volume>: <fpage>1086</fpage>â<lpage>1087</lpage>
<pub-id pub-id-type="pmid">28368693</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0051">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0051">
<string-name>
<surname>Lacher</surname>
<given-names>SE</given-names>
</string-name>, <string-name>
<surname>Slattery</surname>
<given-names>M</given-names>
</string-name> (<year>2016</year>) <article-title>Gene regulatory effects of diseaseâassociated variation in the NRF2 network</article-title>. <source xml:lang="en">Curr Opin Toxicol</source>
<volume>1</volume>: <fpage>71</fpage>â<lpage>79</lpage>
<pub-id pub-id-type="pmid">28203648</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0052">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0052">
<string-name>
<surname>Lamark</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Johansen</surname>
<given-names>T</given-names>
</string-name> (<year>2012</year>) <article-title>Aggrephagy: selective disposal of protein aggregates by macroautophagy</article-title>. <source xml:lang="en">Int J Cell Biol</source>
<volume>2012</volume>: <fpage>736905</fpage>
<pub-id pub-id-type="pmid">22518139</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0053">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0053">
<string-name>
<surname>Lan</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Zhuang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>Z</given-names>
</string-name> (<year>2015</year>) <article-title>Proteasome inhibitorâinduced autophagy in PC12 cells overexpressing A53T mutant alphaâsynuclein</article-title>. <source xml:lang="en">Mol Med Rep</source>
<volume>11</volume>: <fpage>1655</fpage>â<lpage>1660</lpage>
<pub-id pub-id-type="pmid">25434876</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0054">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0054">
<string-name>
<surname>Lansbury</surname>
<given-names>PT</given-names>
</string-name>, <string-name>
<surname>Lashuel</surname>
<given-names>HA</given-names>
</string-name> (<year>2006</year>) <article-title>A centuryâold debate on protein aggregation and neurodegeneration enters the clinic</article-title>. <source xml:lang="en">Nature</source>
<volume>443</volume>: <fpage>774</fpage>â<lpage>779</lpage>
<pub-id pub-id-type="pmid">17051203</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0055">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0055">
<string-name>
<surname>Lau</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>XJ</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Villeneuve</surname>
<given-names>NF</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>White</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>DD</given-names>
</string-name> (<year>2010</year>) <article-title>A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62</article-title>. <source xml:lang="en">Mol Cell Biol</source>
<volume>30</volume>: <fpage>3275</fpage>â<lpage>3285</lpage>
<pub-id pub-id-type="pmid">20421418</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0056">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0056">
<string-name>
<surname>Lim</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Lachenmayer</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Kundu</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Komatsu</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Oh</surname>
<given-names>YJ</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Yue</surname>
<given-names>Z</given-names>
</string-name> (<year>2015</year>) <article-title>Proteotoxic stress induces phosphorylation of p62/SQSTM1 by ULK1 to regulate selective autophagic clearance of protein aggregates</article-title>. <source xml:lang="en">PLoS Genet</source>
<volume>11</volume>: <fpage>e1004987</fpage>
<pub-id pub-id-type="pmid">25723488</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0057">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0057">
<string-name>
<surname>Loboda</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Damulewicz</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Pyza</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Jozkowicz</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Dulak</surname>
<given-names>J</given-names>
</string-name> (<year>2016</year>) <article-title>Role of Nrf2/HOâ1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism</article-title>. <source xml:lang="en">Cell Mol Life Sci</source>
<volume>73</volume>: <fpage>3221</fpage>â<lpage>3247</lpage>
<pub-id pub-id-type="pmid">27100828</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0058">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0058">
<string-name>
<surname>Lystad</surname>
<given-names>AH</given-names>
</string-name>, <string-name>
<surname>Simonsen</surname>
<given-names>A</given-names>
</string-name> (<year>2015</year>) <article-title>Assays to monitor aggrephagy</article-title>. <source xml:lang="en">Methods</source>
<volume>75</volume>: <fpage>112</fpage>â<lpage>119</lpage>
<pub-id pub-id-type="pmid">25555675</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0059">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0059">
<string-name>
<surname>Mandell</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Jain</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>ArkoâMensah</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Chauhan</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kimura</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Dinkins</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Silvestri</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Munch</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kirchhoff</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Simonsen</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Wei</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Levine</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Johansen</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Deretic</surname>
<given-names>V</given-names>
</string-name> (<year>2014a</year>) <article-title>TRIM proteins regulate autophagy and can target autophagic substrates by direct recognition</article-title>. <source xml:lang="en">Dev Cell</source>
<volume>30</volume>: <fpage>394</fpage>â<lpage>409</lpage>
<pub-id pub-id-type="pmid">25127057</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0060">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0060">
<string-name>
<surname>Mandell</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Kimura</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Jain</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Johansen</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Deretic</surname>
<given-names>V</given-names>
</string-name> (<year>2014b</year>) <article-title>TRIM proteins regulate autophagy: TRIM5 is a selective autophagy receptor mediating HIVâ1 restriction</article-title>. <source xml:lang="en">Autophagy</source>
<volume>10</volume>: <fpage>2387</fpage>â<lpage>2388</lpage>
<pub-id pub-id-type="pmid">25587751</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0061">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0061">
<string-name>
<surname>Mandell</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Jain</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Kumar</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Castleman</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Anwar</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Eskelinen</surname>
<given-names>EL</given-names>
</string-name>, <string-name>
<surname>Johansen</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Prekeris</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Deretic</surname>
<given-names>V</given-names>
</string-name> (<year>2016</year>) <article-title>TRIM17 contributes to autophagy of midbodies while actively sparing other targets from degradation</article-title>. <source xml:lang="en">J Cell Sci</source>
<volume>129</volume>: <fpage>3562</fpage>â<lpage>3573</lpage>
<pub-id pub-id-type="pmid">27562068</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0062">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0062">
<string-name>
<surname>Marin</surname>
<given-names>I</given-names>
</string-name> (<year>2012</year>) <article-title>Origin and diversification of TRIM ubiquitin ligases</article-title>. <source xml:lang="en">PLoS One</source>
<volume>7</volume>: <fpage>e50030</fpage>
<pub-id pub-id-type="pmid">23185523</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0063">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0063">
<string-name>
<surname>Motohashi</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Yamamoto</surname>
<given-names>M</given-names>
</string-name> (<year>2004</year>) <article-title>Nrf2âKeap1 defines a physiologically important stress response mechanism</article-title>. <source xml:lang="en">Trends Mol Med</source>
<volume>10</volume>: <fpage>549</fpage>â<lpage>557</lpage>
<pub-id pub-id-type="pmid">15519281</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0064">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0064">
<string-name>
<surname>Nagaoka</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Jana</surname>
<given-names>NR</given-names>
</string-name>, <string-name>
<surname>Doi</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Maruyama</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Mitsui</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Oyama</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Nukina</surname>
<given-names>N</given-names>
</string-name> (<year>2004</year>) <article-title>Increased expression of p62 in expanded polyglutamineâexpressing cells and its association with polyglutamine inclusions</article-title>. <source xml:lang="en">J Neurochem</source>
<volume>91</volume>: <fpage>57</fpage>â<lpage>68</lpage>
<pub-id pub-id-type="pmid">15379887</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0065">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0065">
<string-name>
<surname>Navarro</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ventura</surname>
<given-names>S</given-names>
</string-name> (<year>2014</year>) <article-title>Fluorescent dye ProteoStat to detect and discriminate intracellular amyloidâlike aggregates in Escherichia coli</article-title>. <source xml:lang="en">Biotechnol J</source>
<volume>9</volume>: <fpage>1259</fpage>â<lpage>1266</lpage>
<pub-id pub-id-type="pmid">25112199</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0066">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0066">
<string-name>
<surname>Nazio</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Strappazzon</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Antonioli</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Bielli</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Cianfanelli</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Bordi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Gretzmeier</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Dengjel</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Piacentini</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Fimia</surname>
<given-names>GM</given-names>
</string-name>, <string-name>
<surname>Cecconi</surname>
<given-names>F</given-names>
</string-name> (<year>2013</year>) <article-title>mTOR inhibits autophagy by controlling ULK1 ubiquitylation, selfâassociation and function through AMBRA1 and TRAF6</article-title>. <source xml:lang="en">Nat Cell Biol</source>
<volume>15</volume>: <fpage>406</fpage>â<lpage>416</lpage>
<pub-id pub-id-type="pmid">23524951</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0067">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0067">
<string-name>
<surname>Nezis</surname>
<given-names>IP</given-names>
</string-name>, <string-name>
<surname>Simonsen</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Sagona</surname>
<given-names>AP</given-names>
</string-name>, <string-name>
<surname>Finley</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Gaumer</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Contamine</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Rusten</surname>
<given-names>TE</given-names>
</string-name>, <string-name>
<surname>Stenmark</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Brech</surname>
<given-names>A</given-names>
</string-name> (<year>2008</year>) <article-title>Ref(2)P, the <italic>Drosophila melanogaster</italic> homologue of mammalian p62, is required for the formation of protein aggregates in adult brain</article-title>. <source xml:lang="en">J Cell Biol</source>
<volume>180</volume>: <fpage>1065</fpage>â<lpage>1071</lpage>
<pub-id pub-id-type="pmid">18347073</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0068">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0068">
<string-name>
<surname>Nisole</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Stoye</surname>
<given-names>JP</given-names>
</string-name>, <string-name>
<surname>Saib</surname>
<given-names>A</given-names>
</string-name> (<year>2005</year>) <article-title>TRIM family proteins: retroviral restriction and antiviral defence</article-title>. <source xml:lang="en">Nat Rev Microbiol</source>
<volume>3</volume>: <fpage>799</fpage>â<lpage>808</lpage>
<pub-id pub-id-type="pmid">16175175</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0069">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0069">
<string-name>
<surname>Noguchi</surname>
<given-names>N</given-names>
</string-name> (<year>2008</year>) <article-title>Role of oxidative stress in adaptive responses in special reference to atherogenesis</article-title>. <source xml:lang="en">J Clin Biochem Nutr</source>
<volume>43</volume>: <fpage>131</fpage>â<lpage>138</lpage>
<pub-id pub-id-type="pmid">19015746</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0070">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0070">
<string-name>
<surname>Olzmann</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Chin</surname>
<given-names>LS</given-names>
</string-name> (<year>2008</year>) <article-title>Aggresome formation and neurodegenerative diseases: therapeutic implications</article-title>. <source xml:lang="en">Curr Med Chem</source>
<volume>15</volume>: <fpage>47</fpage>â<lpage>60</lpage>
<pub-id pub-id-type="pmid">18220762</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0071">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0071">
<string-name>
<surname>Pajares</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Cuadrado</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Rojo</surname>
<given-names>AI</given-names>
</string-name> (<year>2017</year>) <article-title>Modulation of proteostasis by transcription factor NRF2 and impact in neurodegenerative diseases</article-title>. <source xml:lang="en">Redox Biol</source>
<volume>11</volume>: <fpage>543</fpage>â<lpage>553</lpage>
<pub-id pub-id-type="pmid">28104575</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0072">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0072">
<string-name>
<surname>Pankiv</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Clausen</surname>
<given-names>TH</given-names>
</string-name>, <string-name>
<surname>Lamark</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Brech</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Bruun</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Outzen</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Overvatn</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Bjorkoy</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Johansen</surname>
<given-names>T</given-names>
</string-name> (<year>2007</year>) <article-title>p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy</article-title>. <source xml:lang="en">J Biol Chem</source>
<volume>282</volume>: <fpage>24131</fpage>â<lpage>24145</lpage>
<pub-id pub-id-type="pmid">17580304</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0073">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0073">
<string-name>
<surname>Polajnar</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Zerovnik</surname>
<given-names>E</given-names>
</string-name> (<year>2014</year>) <article-title>Impaired autophagy: a link between neurodegenerative and neuropsychiatric diseases</article-title>. <source xml:lang="en">J Cell Mol Med</source>
<volume>18</volume>: <fpage>1705</fpage>â<lpage>1711</lpage>
<pub-id pub-id-type="pmid">25139375</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0074">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0074">
<string-name>
<surname>Python</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Goebel</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Aeby</surname>
<given-names>P</given-names>
</string-name> (<year>2009</year>) <article-title>Comparative DNA microarray analysis of human monocyte derived dendritic cells and MUTZâ3 cells exposed to the moderate skin sensitizer cinnamaldehyde</article-title>. <source xml:lang="en">Toxicol Appl Pharmacol</source>
<volume>239</volume>: <fpage>273</fpage>â<lpage>283</lpage>
<pub-id pub-id-type="pmid">19524605</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0075">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0075">
<string-name>
<surname>Ravikumar</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Vacher</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Berger</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Davies</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Luo</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Oroz</surname>
<given-names>LG</given-names>
</string-name>, <string-name>
<surname>Scaravilli</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Easton</surname>
<given-names>DF</given-names>
</string-name>, <string-name>
<surname>Duden</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>O'Kane</surname>
<given-names>CJ</given-names>
</string-name>, <string-name>
<surname>Rubinsztein</surname>
<given-names>DC</given-names>
</string-name> (<year>2004</year>) <article-title>Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease</article-title>. <source xml:lang="en">Nat Genet</source>
<volume>36</volume>: <fpage>585</fpage>â<lpage>595</lpage>
<pub-id pub-id-type="pmid">15146184</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0076">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0076">
<string-name>
<surname>Riley</surname>
<given-names>BE</given-names>
</string-name>, <string-name>
<surname>Kaiser</surname>
<given-names>SE</given-names>
</string-name>, <string-name>
<surname>Shaler</surname>
<given-names>TA</given-names>
</string-name>, <string-name>
<surname>Ng</surname>
<given-names>AC</given-names>
</string-name>, <string-name>
<surname>Hara</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Hipp</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Lage</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Xavier</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>Ryu</surname>
<given-names>KY</given-names>
</string-name>, <string-name>
<surname>Taguchi</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Yamamoto</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Tanaka</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Mizushima</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Komatsu</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kopito</surname>
<given-names>RR</given-names>
</string-name> (<year>2010</year>) <article-title>Ubiquitin accumulation in autophagyâdeficient mice is dependent on the Nrf2âmediated stress response pathway: a potential role for protein aggregation in autophagic substrate selection</article-title>. <source xml:lang="en">J Cell Biol</source>
<volume>191</volume>: <fpage>537</fpage>â<lpage>552</lpage>
<pub-id pub-id-type="pmid">21041446</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0077">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0077">
<string-name>
<surname>Riley</surname>
<given-names>BE</given-names>
</string-name>, <string-name>
<surname>Kaiser</surname>
<given-names>SE</given-names>
</string-name>, <string-name>
<surname>Kopito</surname>
<given-names>RR</given-names>
</string-name> (<year>2011</year>) <article-title>Autophagy inhibition engages Nrf2âp62 Ubâassociated signaling</article-title>. <source xml:lang="en">Autophagy</source>
<volume>7</volume>: <fpage>338</fpage>â<lpage>340</lpage>
<pub-id pub-id-type="pmid">21252622</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0078">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0078">
<string-name>
<surname>Sahni</surname>
<given-names>SK</given-names>
</string-name>, <string-name>
<surname>Rydkina</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Sahni</surname>
<given-names>A</given-names>
</string-name> (<year>2008</year>) <article-title>The proteasome inhibitor MG132 induces nuclear translocation of erythroid transcription factor Nrf2 and cyclooxygenaseâ2 expression in human vascular endothelial cells</article-title>. <source xml:lang="en">Thromb Res</source>
<volume>122</volume>: <fpage>820</fpage>â<lpage>825</lpage>
<pub-id pub-id-type="pmid">18377959</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0079">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0079">
<string-name>
<surname>Sarkar</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Davies</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Tunnacliffe</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Rubinsztein</surname>
<given-names>DC</given-names>
</string-name> (<year>2007</year>) <article-title>Trehalose, a novel mTORâindependent autophagy enhancer, accelerates the clearance of mutant huntingtin and alphaâsynuclein</article-title>. <source xml:lang="en">J Biol Chem</source>
<volume>282</volume>: <fpage>5641</fpage>â<lpage>5652</lpage>
<pub-id pub-id-type="pmid">17182613</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0080">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0080">
<string-name>
<surname>Schubert</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Anton</surname>
<given-names>LC</given-names>
</string-name>, <string-name>
<surname>Gibbs</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Norbury</surname>
<given-names>CC</given-names>
</string-name>, <string-name>
<surname>Yewdell</surname>
<given-names>JW</given-names>
</string-name>, <string-name>
<surname>Bennink</surname>
<given-names>JR</given-names>
</string-name> (<year>2000</year>) <article-title>Rapid degradation of a large fraction of newly synthesized proteins by proteasomes</article-title>. <source xml:lang="en">Nature</source>
<volume>404</volume>: <fpage>770</fpage>â<lpage>774</lpage>
<pub-id pub-id-type="pmid">10783891</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0081">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0081">
<string-name>
<surname>Scott</surname>
<given-names>MD</given-names>
</string-name>, <string-name>
<surname>Frydman</surname>
<given-names>J</given-names>
</string-name> (<year>2003</year>) <article-title>Aberrant protein folding as the molecular basis of cancer</article-title>. <source xml:lang="en">Methods Mol Biol</source>
<volume>232</volume>: <fpage>67</fpage>â<lpage>76</lpage>
<pub-id pub-id-type="pmid">12840540</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0082">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0082">
<string-name>
<surname>Scotter</surname>
<given-names>EL</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>HJ</given-names>
</string-name>, <string-name>
<surname>Shaw</surname>
<given-names>CE</given-names>
</string-name> (<year>2015</year>) <article-title>TDPâ43 Proteinopathy and ALS: insights into Disease Mechanisms and Therapeutic Targets</article-title>. <source xml:lang="en">Neurotherapeutics</source>
<volume>12</volume>: <fpage>352</fpage>â<lpage>363</lpage>
<pub-id pub-id-type="pmid">25652699</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0083">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0083">
<string-name>
<surname>Seibenhener</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>Babu</surname>
<given-names>JR</given-names>
</string-name>, <string-name>
<surname>Geetha</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Wong</surname>
<given-names>HC</given-names>
</string-name>, <string-name>
<surname>Krishna</surname>
<given-names>NR</given-names>
</string-name>, <string-name>
<surname>Wooten</surname>
<given-names>MW</given-names>
</string-name> (<year>2004</year>) <article-title>Sequestosome 1/p62 is a polyubiquitin chain binding protein involved in ubiquitin proteasome degradation</article-title>. <source xml:lang="en">Mol Cell Biol</source>
<volume>24</volume>: <fpage>8055</fpage>â<lpage>8068</lpage>
<pub-id pub-id-type="pmid">15340068</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0084">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0084">
<string-name>
<surname>Selvaraj</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Armistead</surname>
<given-names>MY</given-names>
</string-name>, <string-name>
<surname>Cohenford</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Murray</surname>
<given-names>E</given-names>
</string-name> (<year>2013</year>) <article-title>Arsenic trioxide (As(2)O(3)) induces apoptosis and necrosis mediated cell death through mitochondrial membrane potential damage and elevated production of reactive oxygen species in PLHCâ1 fish cell line</article-title>. <source xml:lang="en">Chemosphere</source>
<volume>90</volume>: <fpage>1201</fpage>â<lpage>1209</lpage>
<pub-id pub-id-type="pmid">23121984</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0085">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0085">
<string-name>
<surname>Seo</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Park</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>EJ</given-names>
</string-name>, <string-name>
<surname>Vo</surname>
<given-names>TT</given-names>
</string-name>, <string-name>
<surname>Choi</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>JY</given-names>
</string-name>, <string-name>
<surname>Jang</surname>
<given-names>JK</given-names>
</string-name>, <string-name>
<surname>Wee</surname>
<given-names>HJ</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>HS</given-names>
</string-name>, <string-name>
<surname>Jang</surname>
<given-names>SH</given-names>
</string-name>, <string-name>
<surname>Park</surname>
<given-names>ZY</given-names>
</string-name>, <string-name>
<surname>Jeong</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>KJ</given-names>
</string-name>, <string-name>
<surname>Seok</surname>
<given-names>SH</given-names>
</string-name>, <string-name>
<surname>Park</surname>
<given-names>JY</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>BJ</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>MN</given-names>
</string-name>, <string-name>
<surname>Oh</surname>
<given-names>GT</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>KW</given-names>
</string-name> (<year>2016</year>) <article-title>ARD1âmediated Hsp70 acetylation balances stressâinduced protein refolding and degradation</article-title>. <source xml:lang="en">Nat Commun</source>
<volume>7</volume>: <fpage>12882</fpage>
<pub-id pub-id-type="pmid">27708256</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0086">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0086">
<string-name>
<surname>Shen</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Coleman</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Chan</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Nicholson</surname>
<given-names>TP</given-names>
</string-name>, <string-name>
<surname>Dai</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Sheppard</surname>
<given-names>PW</given-names>
</string-name>, <string-name>
<surname>Patton</surname>
<given-names>WF</given-names>
</string-name> (<year>2011</year>) <article-title>Novel cellâ and tissueâbased assays for detecting misfolded and aggregated protein accumulation within aggresomes and inclusion bodies</article-title>. <source xml:lang="en">Cell Biochem Biophys</source>
<volume>60</volume>: <fpage>173</fpage>â<lpage>185</lpage>
<pub-id pub-id-type="pmid">21132543</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0087">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0087">
<string-name>
<surname>Svenning</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Johansen</surname>
<given-names>T</given-names>
</string-name> (<year>2013</year>) <article-title>Selective autophagy</article-title>. <source xml:lang="en">Essays Biochem</source>
<volume>55</volume>: <fpage>79</fpage>â<lpage>92</lpage>
<pub-id pub-id-type="pmid">24070473</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0088">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0088">
<string-name>
<surname>Szeto</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kaniuk</surname>
<given-names>NA</given-names>
</string-name>, <string-name>
<surname>Canadien</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Nisman</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Mizushima</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Yoshimori</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>BazettâJones</surname>
<given-names>DP</given-names>
</string-name>, <string-name>
<surname>Brumell</surname>
<given-names>JH</given-names>
</string-name> (<year>2006</year>) <article-title>ALIS are stressâinduced protein storage compartments for substrates of the proteasome and autophagy</article-title>. <source xml:lang="en">Autophagy</source>
<volume>2</volume>: <fpage>189</fpage>â<lpage>199</lpage>
<pub-id pub-id-type="pmid">16874109</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0089">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0089">
<string-name>
<surname>Takaya</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Suzuki</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Motohashi</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Onodera</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Satomi</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kensler</surname>
<given-names>TW</given-names>
</string-name>, <string-name>
<surname>Yamamoto</surname>
<given-names>M</given-names>
</string-name> (<year>2012</year>) <article-title>Validation of the multiple sensor mechanism of the Keap1âNrf2 system</article-title>. <source xml:lang="en">Free Radic Biol Med</source>
<volume>53</volume>: <fpage>817</fpage>â<lpage>827</lpage>
<pub-id pub-id-type="pmid">22732183</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0090">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0090">
<string-name>
<surname>Tanaka</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>YM</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Junn</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Iwatsubo</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Mouradian</surname>
<given-names>MM</given-names>
</string-name> (<year>2004</year>) <article-title>Aggresomes formed by alphaâsynuclein and synphilinâ1 are cytoprotective</article-title>. <source xml:lang="en">J Biol Chem</source>
<volume>279</volume>: <fpage>4625</fpage>â<lpage>4631</lpage>
<pub-id pub-id-type="pmid">14627698</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0091">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0091">
<string-name>
<surname>Tyedmers</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Mogk</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Bukau</surname>
<given-names>B</given-names>
</string-name> (<year>2010</year>) <article-title>Cellular strategies for controlling protein aggregation</article-title>. <source xml:lang="en">Nat Rev Mol Cell Biol</source>
<volume>11</volume>: <fpage>777</fpage>â<lpage>788</lpage>
<pub-id pub-id-type="pmid">20944667</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0092">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0092">
<string-name>
<surname>Vadlamudi</surname>
<given-names>RK</given-names>
</string-name>, <string-name>
<surname>Joung</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Strominger</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Shin</surname>
<given-names>J</given-names>
</string-name> (<year>1996</year>) <article-title>p62, a phosphotyrosineâindependent ligand of the SH2 domain of p56lck, belongs to a new class of ubiquitinâbinding proteins</article-title>. <source xml:lang="en">J Biol Chem</source>
<volume>271</volume>: <fpage>20235</fpage>â<lpage>20237</lpage>
<pub-id pub-id-type="pmid">8702753</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0093">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0093">
<string-name>
<surname>Wang</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Kang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Su</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Xiang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Yi</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Lu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>L</given-names>
</string-name> (<year>2013</year>) <article-title>Regulation of endoplasmic reticulum stress in rat cortex by p62/ZIP through the Keap1âNrf2âARE signalling pathway after transient focal cerebral ischaemia</article-title>. <source xml:lang="en">Brain Inj</source>
<volume>27</volume>: <fpage>924</fpage>â<lpage>933</lpage>
<pub-id pub-id-type="pmid">23782269</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0094">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0094">
<string-name>
<surname>Woo</surname>
<given-names>SH</given-names>
</string-name>, <string-name>
<surname>Park</surname>
<given-names>IC</given-names>
</string-name>, <string-name>
<surname>Park</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>HC</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Chun</surname>
<given-names>YJ</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>SH</given-names>
</string-name>, <string-name>
<surname>Hong</surname>
<given-names>SI</given-names>
</string-name>, <string-name>
<surname>Rhee</surname>
<given-names>CH</given-names>
</string-name> (<year>2002</year>) <article-title>Arsenic trioxide induces apoptosis through a reactive oxygen speciesâdependent pathway and loss of mitochondrial membrane potential in HeLa cells</article-title>. <source xml:lang="en">Int J Oncol</source>
<volume>21</volume>: <fpage>57</fpage>â<lpage>63</lpage>
<pub-id pub-id-type="pmid">12063550</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0095">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0095">
<string-name>
<surname>Xu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Reumers</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Couceiro</surname>
<given-names>JR</given-names>
</string-name>, <string-name>
<surname>De Smet</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Gallardo</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Rudyak</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Cornelis</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Rozenski</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Zwolinska</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Marine</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Lambrechts</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Suh</surname>
<given-names>YA</given-names>
</string-name>, <string-name>
<surname>Rousseau</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Schymkowitz</surname>
<given-names>J</given-names>
</string-name> (<year>2011</year>) <article-title>Gain of function of mutant p53 by coaggregation with multiple tumor suppressors</article-title>. <source xml:lang="en">Nat Chem Biol</source>
<volume>7</volume>: <fpage>285</fpage>â<lpage>295</lpage>
<pub-id pub-id-type="pmid">21445056</pub-id></mixed-citation>
      </ref>
      <ref id="embj201798358-bib-0096">
        <mixed-citation publication-type="journal" id="embj201798358-cit-0096">
<string-name>
<surname>Yao</surname>
<given-names>TP</given-names>
</string-name> (<year>2010</year>) <article-title>The role of ubiquitin in autophagyâdependent protein aggregate processing</article-title>. <source xml:lang="en">Genes Cancer</source>
<volume>1</volume>: <fpage>779</fpage>â<lpage>786</lpage>
<pub-id pub-id-type="pmid">21113398</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>